<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Tomography</journal-id><journal-id journal-id-type="iso-abbrev">Tomography</journal-id><journal-id journal-id-type="publisher-id">tomography</journal-id><journal-title-group><journal-title>Tomography</journal-title></journal-title-group><issn pub-type="ppub">2379-1381</issn><issn pub-type="epub">2379-139X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39997999</article-id><article-id pub-id-type="pmc">PMC11861380</article-id>
<article-id pub-id-type="doi">10.3390/tomography11020016</article-id><article-id pub-id-type="publisher-id">tomography-11-00016</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Multiparametric Magnetic Resonance Imaging Findings of the Pancreas: A Comparison in Patients with Type 1 and 2 Diabetes</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3929-9495</contrib-id><name><surname>Higashi</surname><given-names>Mayumi</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af1-tomography-11-00016" ref-type="aff">1</xref><xref rid="c1-tomography-11-00016" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0302-4257</contrib-id><name><surname>Tanabe</surname><given-names>Masahiro</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><xref rid="af1-tomography-11-00016" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9802-0584</contrib-id><name><surname>Tanabe</surname><given-names>Katsuya</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af2-tomography-11-00016" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4405-3193</contrib-id><name><surname>Okuya</surname><given-names>Shigeru</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="af3-tomography-11-00016" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Takeda</surname><given-names>Koumei</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="af2-tomography-11-00016" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Nagao</surname><given-names>Yuko</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="af2-tomography-11-00016" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Ito</surname><given-names>Katsuyoshi</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><xref rid="af1-tomography-11-00016" ref-type="aff">1</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Schreyer</surname><given-names>Andreas G.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-tomography-11-00016"><label>1</label>Department of Radiology, Yamaguchi University Graduate School of Medicine, Yamaguchi 755-8505, Japan; <email>m-tanabe@yamaguchi-u.ac.jp</email> (M.T.); <email>itokatsu@yamaguchi-u.ac.jp</email> (K.I.)</aff><aff id="af2-tomography-11-00016"><label>2</label>Division of Endocrinology, Metabolism, Hematological Sciences and Therapeutics, Yamaguchi University Graduate School of Medicine, Yamaguchi 755-8505, Japan; <email>ktanabe@yamaguchi-u.ac.jp</email> (K.T.); </aff><aff id="af3-tomography-11-00016"><label>3</label>Health Administration Center, Organization for Education and Student Affairs, Yamaguchi 753-8511, Japan; <email>okuya@yamaguchi-u.ac.jp</email></aff><author-notes><corresp id="c1-tomography-11-00016"><label>*</label>Correspondence: <email>mhigashi@yamaguchi-u.ac.jp</email></corresp></author-notes><pub-date pub-type="epub"><day>07</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>11</volume><issue>2</issue><elocation-id>16</elocation-id><history><date date-type="received"><day>09</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>28</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>05</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Background/Objectives: Diabetes-related pancreatic changes on MRI remain unclear. Thus, we evaluated the pancreatic changes on MRI in patients with both type 1 diabetes (T1D) and type 2 diabetes (T2D) using multiparametric MRI. Methods: This prospective study involved patients with T1D or T2D who underwent upper abdominal 3-T MRI. Additionally, patients without impaired glucose metabolism were retrospectively included as a control. The imaging data included pancreatic anteroposterior (AP) diameter, pancreas-to-muscle signal intensity ratio (SIR) on fat-suppressed T1-weighted image (FS-T1WI), apparent diffusion coefficient (ADC) value, T1 value on T1 map, proton density fat fraction (PDFF), and mean secretion grade of pancreatic juice flow on cine-dynamic magnetic resonance cholangiopancreatography (MRCP). The MR measurements were compared using one-way analysis of variance and the Kruskal&#x02013;Wallis test. Results: Sixty-one patients with T1D (<italic toggle="yes">n</italic> = 7) or T2D (<italic toggle="yes">n</italic> = 54) and 21 control patients were evaluated. The pancreatic AP diameters were significantly smaller in patients with T1D than in patients with T2D (<italic toggle="yes">p</italic> &#x0003c; 0.05). The average SIR on FS-T1WI was significantly lower in patients with T1D than in controls (<italic toggle="yes">p</italic> &#x0003c; 0.001). The average ADC and T1 values of the pancreas were significantly higher in patients with T1D than in patients with T2D (<italic toggle="yes">p</italic> &#x0003c; 0.01) and controls (<italic toggle="yes">p</italic> &#x0003c; 0.05). The mean secretion grade of pancreatic juice flow was significantly lower in patients with T1D than in controls (<italic toggle="yes">p</italic> = 0.019). The average PDFF of the pancreas was significantly higher in patients with T2D than in controls (<italic toggle="yes">p</italic> = 0.029). Conclusions: Patients with T1D had reduced pancreas size, increased pancreatic T1 and ADC values, and decreased pancreatic juice flow on cine-dynamic MRCP, whereas patients with T2D had increased pancreatic fat content.</p></abstract><kwd-group><kwd>pancreas</kwd><kwd>diabetes mellitus</kwd><kwd>magnetic resonance imaging</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-tomography-11-00016"><title>1. Introduction</title><p>Diabetes is a chronic metabolic disorder characterized by hyperglycemia resulting from insulin deficiency, insulin resistance, or a combination of both. It has many subclassifications, but the vast majority of diabetes cases can be divided into two main categories: type 1 diabetes (T1D) and type 2 diabetes (T2D), each with a different pathophysiology, presentation, and management [<xref rid="B1-tomography-11-00016" ref-type="bibr">1</xref>].</p><p>T1D, which constitutes only 5&#x02013;10% of diabetes, is characterized by an absolute insulin deficiency resulting from cellular-mediated autoimmune destruction of &#x003b2;-cells in the pancreas. In contrast, T2D, which accounts for 90&#x02013;95% of those with diabetes, involves a complex interplay between genetics and environmental factors and ranges from predominantly insulin resistance with relative insulin deficiency to predominantly impaired insulin secretion with insulin resistance [<xref rid="B1-tomography-11-00016" ref-type="bibr">1</xref>,<xref rid="B2-tomography-11-00016" ref-type="bibr">2</xref>]. In both categories, pancreatic exocrine insufficiency, which is defined by a deficiency of pancreatic enzymes resulting in maldigestion [<xref rid="B3-tomography-11-00016" ref-type="bibr">3</xref>], can also be observed (26&#x02013;74% of patients with T1D and 10&#x02013;56% of patients with T2D), and its mechanism is associated with multiple factors, including some histopathological changes, such as pancreatic atrophy and fibrosis [<xref rid="B4-tomography-11-00016" ref-type="bibr">4</xref>].</p><p>In recent years, there have been significant advancements in image-based diagnostics and treatments in the oncological field [<xref rid="B5-tomography-11-00016" ref-type="bibr">5</xref>,<xref rid="B6-tomography-11-00016" ref-type="bibr">6</xref>]. Beyond conventional imaging techniques, such as computed tomography (CT) and magnetic resonance imaging (MRI), a new image analysis technique based on algorithms that allow for the extraction of imaging features from radiological images, known as radiomics, has been applied to improve diagnosis, prognostication, and treatment planning with the aim of delivering personalized medicine [<xref rid="B7-tomography-11-00016" ref-type="bibr">7</xref>,<xref rid="B8-tomography-11-00016" ref-type="bibr">8</xref>,<xref rid="B9-tomography-11-00016" ref-type="bibr">9</xref>]. In the field of diabetes, a few studies using CT have found that the radiomics signature of the pancreas shows the highest discriminatory ability for early diabetes screening and prediction of T2D [<xref rid="B10-tomography-11-00016" ref-type="bibr">10</xref>,<xref rid="B11-tomography-11-00016" ref-type="bibr">11</xref>]. However, CT is not suitable for repeated measurements in young populations, such as patients with T1D, due to the high radiation dose associated with abdominal imaging. Therefore, it is preferable to utilize other noninvasive modalities, such as MRI, for image analysis in diabetes.</p><p>The utility of MRI to detect changes in images reflecting pancreatic histological and pathophysiological alterations in patients with diabetes has been increasingly explored [<xref rid="B12-tomography-11-00016" ref-type="bibr">12</xref>,<xref rid="B13-tomography-11-00016" ref-type="bibr">13</xref>]. For example, previous studies have shown that pancreatic volume measurements using MRI are reduced in patients with both T1D and T2D [<xref rid="B14-tomography-11-00016" ref-type="bibr">14</xref>]. In studies of individuals with T2D, the T1 value of the pancreas on the T1 map &#x0003c; images, suggested as a marker of fibrosis, was found to be positively correlated with glycosylated hemoglobin (HbA1c) [<xref rid="B15-tomography-11-00016" ref-type="bibr">15</xref>]. However, diabetes-related pancreatic changes on MRI, especially those in patients with T1D and differences from those in patients with T2D, remain unclear. In addition, most previous studies evaluated pancreatic images with only one or two limited MRI parameters or included limited clinical data.</p><p>Therefore, the present study evaluated the pancreatic changes on MRI in both T1D and T2D patient groups and clarified the differences in the imaging findings of the pancreas between these categories of patients versus those without diabetes as a control group &#x0003c; using multiparametric MRI.</p></sec><sec id="sec2-tomography-11-00016"><title>2. Materials and Methods</title><sec id="sec2dot1-tomography-11-00016"><title>2.1. Study Population</title><p>The institutional review board of our hospital approved this prospective study, and written informed consent was obtained from all patients before the investigation. We recruited consecutive eligible patients with T1D or T2D who were able to undergo upper abdominal MRI at the outpatient clinic of our hospital between January 2021 and January 2023. Glycemic status had been confirmed to meet the criteria for diabetes defined by the Japan Diabetes Society [<xref rid="B16-tomography-11-00016" ref-type="bibr">16</xref>]. For T1D, the patients had reached an insulin-dependent state with autoantibodies against islet antigens that had been confirmed to arise since the onset or during the course of the disease. The inclusion criteria for patients with T1D and patients with T2D were as follows: (i) age of 40&#x02013;75 years old; (ii) HbA1c &#x02264; 11%; and (iii) a body mass index (BMI) of 16&#x02013;37 kg/m<sup>2</sup>. Patients were excluded from this study if any of the following conditions were diagnosed at registration: (i) renal failure (estimated glomerular filtration rate &#x0003c; 30 mL/min/1.73 m<sup>2</sup>); (ii) serious liver disease (liver cirrhosis or aspartate aminotransferase [AST] and aspartate transaminase [ALT] &#x02265; 100 IU/L); (iii) serious heart disease (i.e., heart failure or unstable angina pectoris); and (iv) contraindications for MRI. In addition, patients who were administered anti-cancer drugs and glucocorticoids and those with a medical history of hepatobiliary-gallbladder disease, gastrointestinal surgery, exocrine insufficiency or pancreatitis, or excessive alcohol consumption were excluded from this study.</p><p>For T1D, patients with established T1D were enrolled in this study. Patients within one year of T1D onset (recent onset) and those who had been diagnosed with fulminant T1D were excluded. Patients with T2D who had been under medical management for at least three years were also enrolled in order to include patients with established T2D and exclude patients with pancreatic cancer-associated diabetes. Patients diagnosed with diabetes before 25 years old and those who had a family history of diabetes in the past 3 generations were not enrolled in order to preclude maturity-onset diabetes of the young (MODY). Other etiologies of diabetes were excluded based on the following: (i) the absence of acanthosis nigricans or polycystic ovary syndrome and (ii) the absence of features consistent with maternally inherited diabetes and deafness or a renal cyst and diabetes syndrome (MODY5).</p><p>As a control group, we retrospectively included 21 patients without an impaired glucose metabolism (confirmed by HbA1c value), a history of diabetes, and pancreatic diseases, excluding pancreatic cysts, who met the above inclusion criteria for the age and BMI and underwent upper abdominal MRI during the same period of inclusion.</p></sec><sec id="sec2dot2-tomography-11-00016"><title>2.2. Clinical Data</title><p>For patients with diabetes, the following clinical information and laboratory test results were recorded at the time of MRI examination. Clinical information included the age, gender, age at diabetes onset, duration of diabetes, and BMI. Laboratory tests were conducted under fasting conditions on the same day of imaging as follows: HbA1c, fasting plasma glucose (FPG), C-peptide immunoreactivity (CPR), and glucagon for pancreatic endocrine function tests; P-amylase and lipase for pancreatic exocrine function tests; triglyceride (TG), high-density lipoprotein-cholesterol (HDL-C), and low-density lipoprotein-cholesterol (LDL-C) for lipid tests; AST and ALT for liver function tests; creatinine (Cr) and urine albumin for renal function tests. Plasma glucagon levels were measured using a sandwich ELISA (Mercodia AB, Uppsala, Sweden). The C-peptide index (CPI) was calculated using the following formula: fasting CPR/FPG [<xref rid="B17-tomography-11-00016" ref-type="bibr">17</xref>]. For control patients, clinical data included the age, gender, BMI, and HbA1c at the time of MRI examination. These clinical data were extracted from the electronic clinical records.</p></sec><sec id="sec2dot3-tomography-11-00016"><title>2.3. MRI Technique</title><p>MRI was performed using a 3-T clinical MRI system (Vantage Centurian, Canon Medical Systems, Tochigi, Japan) equipped with a 16-channel body coil. The patients fasted for at least 4 h before MRI. Our routine protocol for pancreatic MRI included in-phase (IP) and opposed-phase (OP) two-dimensional (2D) T1-weighted gradient-echo (GRE) images, fat-suppressed three-dimensional (3D) T1-weighted GRE images, apparent diffusion coefficient (ADC) maps obtained by axial free-breathing diffusion-weighted imaging with a single-shot echo-planar sequence, T1 maps obtained using the modified Look&#x02013;Locker method, proton density fat fraction (PDFF) maps obtained by axial breath-hold six-point Dixon imaging, and cine-dynamic MR cholangiopancreatography (MRCP) with a spatially selective inversion recovery (IR) pulse. The imaging parameters of each MRI sequence are listed in <xref rid="tomography-11-00016-t001" ref-type="table">Table 1</xref>. IP and OP images were obtained to measure the pancreatic diameter. Fat-suppressed T1-weighted images (FS-T1WI), ADC maps, and T1 maps were obtained for assessing the pancreatic fibrosis [<xref rid="B18-tomography-11-00016" ref-type="bibr">18</xref>,<xref rid="B19-tomography-11-00016" ref-type="bibr">19</xref>,<xref rid="B20-tomography-11-00016" ref-type="bibr">20</xref>]. PDFF maps were obtained to evaluate the pancreatic fat content. For the assessment of pancreatic exocrine function, cine-dynamic MRCP with a spatially selective IR pulse was performed [<xref rid="B21-tomography-11-00016" ref-type="bibr">21</xref>].</p><p>For cine-dynamic MRCP with a spatially selective IR pulse, a breath-hold, thick-slab MRCP image was obtained as a reference using a fast advanced spin-echo sequence in the coronal plane. Next, using the same MR sequence, a spatially selective IR pulse (inversion time, 2200 ms) with a width of 20 mm was placed as perpendicular as possible to the main pancreatic duct to nullify the static pancreatic juice signal. Within the area of the spatially selective IR pulse, the static pancreatic juice showed a low signal intensity, whereas the secretory flow of the pancreatic juice showed a high signal intensity (<xref rid="tomography-11-00016-f001" ref-type="fig">Figure 1</xref>). MRCP with a spatially selective IR pulse was repeatedly performed every 15 s (with 5 s of scanning and 10 s of rest) for 5 min (20 images in total), and a series of these MRCP images was referred to as cine-dynamic MRCP with a spatially selective IR pulse [<xref rid="B22-tomography-11-00016" ref-type="bibr">22</xref>].</p></sec><sec id="sec2dot4-tomography-11-00016"><title>2.4. Image Analyses</title><p>Two radiologists (M.H. and M.T., with 9 and 22 years of clinical experience, respectively) evaluated the images in consensus. The radiologists were blinded to the patients&#x02019; clinical information. Measurements of the pancreatic anteroposterior (AP) diameter were performed at the pancreatic head, body, and tail on OP images [<xref rid="B23-tomography-11-00016" ref-type="bibr">23</xref>]. The radiologists measured the ADC value and PDFF of the pancreatic head, body, and tail on the ADC and PDFF map &#x0003c; images using operator-defined circular regions of interest (ROIs). The ROI circles were drawn as large as possible in a homogeneous area of the pancreas while avoiding the main pancreatic duct, focal lesions, and artifacts. T1 values were also measured at the pancreatic head and two locations on the pancreatic body or tail on the T1 map &#x0003c; images. In addition, they measured the signal intensities (SIs) of the pancreatic head, body, tail (SI<sub>pancreas</sub>), and paraspinal muscle (SI<sub>muscle</sub>) using FS-T1WI to calculate the SI ratio (SIR: SI<sub>pancreas</sub>/SI<sub>muscle</sub>). For these measurements, average values were used for the data analysis.</p><p>Cine-dynamic MRCP images were assessed independently by 2 radiologists (M.H. and K.I., with 9 and 36 years of clinical experience, respectively). Any discrepancies between reviewers were resolved by consensus. The MR images were assessed for (a) the frequency of the pancreatic juice flow observed in the main pancreatic duct over the 5-min imaging period (20 images) and (b) the secretion grade of the pancreatic juice, which was categorized based on the movement distance of the pancreatic juice flow within the area of a spatially selective IR pulse using a 5-point secretion grade score (grade 0, no flow; grade 1, &#x0003c;5 mm; grade 2, 5&#x02013;10 mm; grade 3, 11&#x02013;15 mm; grade 4, &#x0003e;15 mm) [<xref rid="B22-tomography-11-00016" ref-type="bibr">22</xref>]. The mean secretion grade of the pancreatic juice was calculated as follows: (total grade score)/20.</p></sec><sec id="sec2dot5-tomography-11-00016"><title>2.5. Statistical Analyses</title><p>Statistical analyses were performed by using the SPSS software program (version 27.0; IBM, Armonk, NY, USA). Normality was assessed using the Shapiro&#x02013;Wilk test. The differences in clinical data between the T1D and T2D groups were evaluated by two-sample <italic toggle="yes">t</italic>-test for FPG, LDL-C, and Cr (normally distributed data) and Mann&#x02013;Whitney <italic toggle="yes">U</italic> test for age at diabetes onset, duration of diabetes, CPR, CPI, glucagon, P-amylase, lipase, TG, HDL-C, AST, ALT, and urine albumin (non-normally distributed data). Fisher&#x02019;s exact test was used to assess the differences in gender among the T1D, T2D, and control groups. The differences in clinical data and MR measurements among the T1D, T2D, and control groups were assessed using one-way analysis of variance with Tukey&#x02019;s post hoc test for BMI and pancreatic AP diameter (normally distributed data), and Kruskal&#x02013;Wallis test with Dunn&#x02019;s post hoc test for age, HbA1c, SIR on FS-T1WI, ADC value, T1 value, PDFF and cine-dynamic MRCP findings (non-normally distributed data). The correlations between the MRI measurements in patients with diabetes were evaluated using Spearman&#x02019;s rank correlation coefficient analysis. Statistical significance was set at <italic toggle="yes">p</italic> &#x0003c; 0.05. To determine the magnitude of differences in MR measurements among the T1D, T2D, and control groups, effect sizes were calculated using partial eta-squared (&#x003b7;<sup>2</sup>) for the one-way analysis of variance and r for the non-parametric test. The effect sizes were interpreted as small (0.01&#x02013;0.05), medium (0.06&#x02013;0.13), and large (&#x02265;0.14) for &#x003b7;<sup>2</sup>, and as small (0.10&#x02013;0.29), medium (0.30&#x02013;0.49), and large (&#x02265;0.50) for r. The interobserver agreement between the 2 reviewers was assessed using weighted Cohen&#x02019;s &#x003ba; statistics and interpreted as follows: 0.21&#x02013;0.40, fair agreement; 0.41&#x02013;0.60, moderate agreement; 0.61&#x02013;0.80, substantial agreement; and 0.81&#x02013;1.00, excellent agreement.</p></sec></sec><sec sec-type="results" id="sec3-tomography-11-00016"><title>3. Results</title><sec id="sec3dot1-tomography-11-00016"><title>3.1. Patient Characteristics</title><p>A total of 67 patients with diabetes met the inclusion criteria. Among these patients, six were excluded because of suboptimal image quality on ADC maps, PDFF maps, or T1 maps. Ultimately, 61 patients with T1D (n = 7) or T2D (n = 54) and 21 control patients were enrolled in this study. Missing data were identified randomly in several clinical variables as follows: urine albumin (n = 1) in T1D; CPR (n = 1), CPI (n = 1), glucagon (n = 1), P-amylase (n = 1), lipase (n = 1) and urine albumin (n = 6) in patients with T2D. In the comparison of each clinical variable between the groups, cases with missing data were excluded from the analysis. The patient characteristics are summarized in <xref rid="tomography-11-00016-t002" ref-type="table">Table 2</xref>.</p><p>The patient age was significantly lower in the T1D group &#x0003c; than in the T2D (<italic toggle="yes">p</italic> = 0.016) and control (<italic toggle="yes">p</italic> = 0.004) groups, while no significant differences were found in the patient age between the T2D and control groups (<italic toggle="yes">p</italic> = 0.799). The BMI was significantly higher in the T2D group &#x0003c; than in the T1D (<italic toggle="yes">p</italic> = 0.033) and control groups (<italic toggle="yes">p</italic> &#x0003c; 0.001), while there were no significant differences in the BMI between the T1D and control groups (<italic toggle="yes">p</italic> = 1.000). In the comparison between the T1D and T2D groups, the T1D group &#x0003c; had lower levels of CPR, CPI, P-amylase, lipase, TG, AST, ALT, and urine albumin than the T2D group (<italic toggle="yes">p</italic> &#x0003c; 0.05) but higher HDL-C levels (<italic toggle="yes">p</italic> = 0.001). No significant differences were observed in the gender, age at diabetes onset, duration of diabetes, HbA1c, FPG, glucagon, LDL-C, or Cr between the two diabetes groups.</p></sec><sec id="sec3dot2-tomography-11-00016"><title>3.2. The Comparison of MR Measurements Among the T1D, T2D, and Control Groups</title><p>A comparison of MR measurements among the three groups is shown in <xref rid="tomography-11-00016-f002" ref-type="fig">Figure 2</xref> and <xref rid="tomography-11-00016-f003" ref-type="fig">Figure 3</xref>, and <xref rid="tomography-11-00016-t003" ref-type="table">Table 3</xref>. The pancreatic AP diameters in the T1D group &#x0003c; were significantly smaller than those in the T2D group (<italic toggle="yes">p</italic> &#x0003c; 0.01). The AP diameters of the pancreatic body and tail in the T1D group &#x0003c; were also significantly smaller than those in the control group (<italic toggle="yes">p</italic> &#x0003c; 0.05). The &#x003b7;<sup>2</sup> values for the pancreatic AP diameters ranged from 0.13 to 0.16, indicating a medium to large effect size. The average SIR on FS-T1WI in the T1D group &#x0003c; was significantly lower than that in the control group (<italic toggle="yes">p</italic> &#x0003c; 0.001, large effect size [<italic toggle="yes">r</italic> = 0.67]), and the SIR of the pancreatic body on FS-T1WI in the T1D group &#x0003c; was significantly lower than that in the T2D group (<italic toggle="yes">p</italic> = 0.008, medium effect size [<italic toggle="yes">r</italic> = 0.39]). The average ADC and T1 values of the pancreas in the T1D group &#x0003c; were significantly higher than those in the T2D (<italic toggle="yes">p</italic> &#x0003c; 0.001, large effect size [<italic toggle="yes">r</italic> = 0.50], and <italic toggle="yes">p</italic> = 0.001, medium effect size [<italic toggle="yes">r</italic> = 0.43], respectively) and control (<italic toggle="yes">p</italic> = 0.015, large effect size [<italic toggle="yes">r</italic> = 0.59], and <italic toggle="yes">p</italic> = 0.010, large effect size [<italic toggle="yes">r</italic> = 0.65], respectively) groups. No significant differences were observed in the PDFF of the pancreas between the T1D group &#x0003c; and both the T2D and control groups. In cine-dynamic MRCP, the interobserver agreement for the frequency of the detection of pancreatic juice flow and the grading of the moving distance of the pancreatic juice flow was excellent (&#x003ba; value = 0.942, 95% confidence interval of 0.929&#x02013;0.955). The frequency and mean secretion grade of pancreatic juice flow in the T1D group &#x0003c; were significantly lower than those in the control group (<italic toggle="yes">p</italic> = 0.016, medium effect size [<italic toggle="yes">r</italic> = 0.47] and <italic toggle="yes">p</italic> = 0.019, medium effect size [<italic toggle="yes">r</italic> = 0.49], respectively).</p><p>Regarding the MRI measurements in the T2D group, the average SIR on FS-T1WI was significantly lower (<italic toggle="yes">p</italic> = 0.006, medium effect size [<italic toggle="yes">r</italic> = 0.36]) and the average PDFF of the pancreas significantly higher (<italic toggle="yes">p</italic> = 0.029, medium effect size [<italic toggle="yes">r</italic> = 0.31]) than in the control group. However, no significant differences were found in the pancreatic AP diameters, ADC and T1 values of the pancreas, or the frequency and mean secretion grade of the pancreatic juice flow between the T2D and control groups.</p></sec><sec id="sec3dot3-tomography-11-00016"><title>3.3. The Correlation Between MR Measurements in Patients with T1D and T2D</title><p>The correlation between the MR measurements in patients with diabetes is shown in <xref rid="tomography-11-00016-t004" ref-type="table">Table 4</xref>. The AP diameters of the pancreatic body and tail showed significant negative correlations with the T1 values of the pancreas (<italic toggle="yes">r</italic> = &#x02212;0.407, <italic toggle="yes">p</italic> = 0.001 and <italic toggle="yes">r</italic> = &#x02212;0.342, <italic toggle="yes">p</italic> = 0.007, respectively). The AP diameter of the pancreatic head showed a significant positive correlation with the PDFF of the pancreas (<italic toggle="yes">r</italic> = 0.330, <italic toggle="yes">p</italic> = 0.009). The SIR of the pancreatic head and body on FS-T1WI showed significant negative correlations with the T1 values (<italic toggle="yes">r =</italic> &#x02212;0.478, <italic toggle="yes">p</italic> &#x0003c; 0.001 and <italic toggle="yes">r</italic> = &#x02212;0.291, <italic toggle="yes">p</italic> = 0.023, respectively) and PDFF of the pancreas (<italic toggle="yes">r</italic> = &#x02212;0.360, <italic toggle="yes">p</italic> = 0.004 and <italic toggle="yes">r</italic> = &#x02212;0.262, <italic toggle="yes">p</italic> = 0.042, respectively), and also showed significant positive correlations with the mean secretion grade of pancreatic juice flow (<italic toggle="yes">r</italic> = 0.293, <italic toggle="yes">p</italic> = 0.022 and <italic toggle="yes">r</italic> = 0.392, <italic toggle="yes">p</italic> = 0.002, respectively). The ADC values of the pancreatic body and tail showed significant negative correlations with the PDFF of the pancreas (<italic toggle="yes">r</italic> = &#x02212;0.274, <italic toggle="yes">p</italic> = 0.032 and <italic toggle="yes">r</italic> = &#x02212;0.263, <italic toggle="yes">p</italic> = 0.043, respectively). The T1 value of the pancreatic head showed a significant positive correlation with the PDFF of the pancreas (<italic toggle="yes">r</italic> = 0.276, <italic toggle="yes">p</italic> = 0.031). There were no significant correlations among the other variables.</p></sec></sec><sec sec-type="discussion" id="sec4-tomography-11-00016"><title>4. Discussion</title><p>Regarding the patient characteristics in this study, patients with T1D were significantly younger than T2D and control patients, which may be primarily attributed to the early onset and diagnosis of T1D [<xref rid="B1-tomography-11-00016" ref-type="bibr">1</xref>]. The results of pancreatic function tests showed that the levels of CPR, CPI, P-amylase, and lipase were lower in patients with T1D than in patients with T2D, but the levels of HbA1c and FPG were not different between patients with T1D and patients with T2D. These observations indicate that glycemic status was not different in both patients, but T1D had lower levels of insulin and pancreatic digestive enzymes. Our results related to lipids showed that the TG level was higher and the HDL-C level was lower in patients with T2D than in patients with T1D. These findings suggest that patients with T2D were more associated with dyslipidemia, and they also had a high BMI compared to T1D and control patients. As for the liver and renal functions, the levels of AST, ALT, and urine albumin were higher in patients with T2D than in patients with T1D, suggesting that the liver and renal functions were more likely to be impaired in patients with T2D than in patients with T1D, although there was no marked decline in these functions in patients with T2D.</p><p>Our findings showed that the pancreas size was significantly reduced in patients with T1D compared to patients with T2D and control patients. Pancreatic size is known to decrease with age [<xref rid="B24-tomography-11-00016" ref-type="bibr">24</xref>], but we found that patients with T1D in this study had significantly smaller pancreas diameters despite being significantly younger than T2D and control patients. In contrast, no significant difference was observed in pancreas size between the T2D and control groups. Most studies have demonstrated that the pancreas size is decreased in both patients with T1D and patients with T2D and that this change in the pancreas is more prominent in patients with T1D than in patients with T2D [<xref rid="B13-tomography-11-00016" ref-type="bibr">13</xref>,<xref rid="B14-tomography-11-00016" ref-type="bibr">14</xref>]. The reduction in pancreas size is associated with the lack of insulin-trophic effects on acinar cells due to insulin deficiency [<xref rid="B25-tomography-11-00016" ref-type="bibr">25</xref>] as well as being a consequence of immunological destruction of the exocrine pancreas [<xref rid="B26-tomography-11-00016" ref-type="bibr">26</xref>]. Therefore, our study findings may be explained by the differences in pathophysiology between T1D and T2D, supported by the clinical data of decreased C-peptide values and pancreatic digestive enzymes in patients with T1D and the relative preservation of both in patients with T2D.</p><p>Furthermore, the frequency and mean secretion grade of pancreatic juice flow were significantly decreased in patients with T1D, while those in patients with T2D were not significantly different from those in control patients. A previous study has shown that cine-dynamic MRCP with a spatially selective IR pulse has the potential to estimate pancreatic exocrine function and that a cutoff value of 0.7 for the mean secretion grade is the criterion for pancreatic exocrine insufficiency [<xref rid="B21-tomography-11-00016" ref-type="bibr">21</xref>]. Thus, our findings suggest that patients with T1D had an impaired pancreatic exocrine function probably due to structural and functional reduction of acinar and beta-cell, whereas patients with T2D with their relatively well-preserved secretion of pancreatic digestive enzymes and insulin in this study had a preserved pancreatic exocrine function.</p><p>In this study, the SIR on FS-T1WI was significantly reduced in patients with T1D and T2D compared to control patients. In addition, the T1 and ADC values of the pancreas were significantly increased in patients with T1D compared to those in T2D and control patients, whereas no marked differences were found in the T1 or ADC values of the pancreas between T2D and control patients. Previous studies have demonstrated that pancreas-to-muscle SIR on T1-weighted imaging and ADC values of the pancreas are associated with pancreatic fibrosis [<xref rid="B18-tomography-11-00016" ref-type="bibr">18</xref>,<xref rid="B19-tomography-11-00016" ref-type="bibr">19</xref>]. T1 values on T1 mapping have also been correlated with histological measurements of fibrosis [<xref rid="B20-tomography-11-00016" ref-type="bibr">20</xref>] and have been reported to be associated with chronic inflammation in the pancreas [<xref rid="B27-tomography-11-00016" ref-type="bibr">27</xref>]. In addition, the ADC values reflect an amalgamation of cell density, cell membrane integrity, and viscosity in biological tissue [<xref rid="B12-tomography-11-00016" ref-type="bibr">12</xref>]. Based on these data, our findings suggest a significant decrease in pancreatic cellular density and markedly increased pancreatic fibrosis or chronic inflammation in patients with T1D and mild changes in patients with T2D. Some results of our study are not compatible with those of previous studies [<xref rid="B15-tomography-11-00016" ref-type="bibr">15</xref>,<xref rid="B28-tomography-11-00016" ref-type="bibr">28</xref>,<xref rid="B29-tomography-11-00016" ref-type="bibr">29</xref>], showing that the T1 and ADC values of the pancreas were significantly increased in patients with T2D. The pathophysiology of T2D is heterogeneous and depends on the disease stage [<xref rid="B1-tomography-11-00016" ref-type="bibr">1</xref>]. In addition, some previous studies included patients with T2D according to HbA1c values, and the clinical backgrounds of these patients have not been well documented. Thus, the differences in the clinical background characteristics of patients with T2D may explain the discrepancies between our results and those of previous studies.</p><p>Regarding pancreatic fat content, the PDFF of the pancreas was significantly increased in patients with T2D, which might reflect a paracrine effect of insulin that can induce fat deposition in the pancreatic parenchyma. This finding is consistent with previous studies using MRI, which found a higher pancreatic fat content in patients with T2D than in control patients [<xref rid="B14-tomography-11-00016" ref-type="bibr">14</xref>,<xref rid="B30-tomography-11-00016" ref-type="bibr">30</xref>,<xref rid="B31-tomography-11-00016" ref-type="bibr">31</xref>,<xref rid="B32-tomography-11-00016" ref-type="bibr">32</xref>,<xref rid="B33-tomography-11-00016" ref-type="bibr">33</xref>]. Furthermore, a fatty pancreas can be associated with obesity and dyslipidemia [<xref rid="B33-tomography-11-00016" ref-type="bibr">33</xref>,<xref rid="B34-tomography-11-00016" ref-type="bibr">34</xref>,<xref rid="B35-tomography-11-00016" ref-type="bibr">35</xref>]. Therefore, the relatively high BMI and TG values and relatively low HDL-C values in patients with T2D in this study may also explain our results. Conversely, the PDFF of the pancreas in patients with T1D was not significantly different from that in control patients. Our findings suggest that pancreatic fat content may not be altered in patients with T1D, which is in agreement with the results of a previous study on children with T1D [<xref rid="B36-tomography-11-00016" ref-type="bibr">36</xref>]. However, pancreatic fat content has been reported to increase with aging [<xref rid="B37-tomography-11-00016" ref-type="bibr">37</xref>]. Thus, the significantly lower age of patients with T1D compared to control patients may have contributed to the absence of increased pancreatic fat content in patients with T1D.</p><p>In patients with diabetes, we found that the size of the pancreatic body and tail tended to decrease with the increase in the T1 values associated with pancreatic fibrosis. This result may be supported by the fact that diabetes has a harmful impact on the progression of chronic pancreatitis by aggravating fibrosis, leading to pancreatic atrophy [<xref rid="B38-tomography-11-00016" ref-type="bibr">38</xref>], and suggests that fibrosis-induced pancreatic atrophy in diabetes, as seen in patients with T1D in this study, may occur more prominently in the body and tail of the pancreas. On the other hand, the size of the pancreatic head tended to increase with increased PDFF of the pancreas. Previous studies have shown that fatty infiltration is usually most prominent in the pancreatic head [<xref rid="B39-tomography-11-00016" ref-type="bibr">39</xref>], and the AP diameter of the pancreatic head in patients with intense fatty infiltration is larger than that in the control group [<xref rid="B40-tomography-11-00016" ref-type="bibr">40</xref>]. Our finding suggests that this change in the pancreatic head can occur in patients with diabetes as well. In addition, our findings showed that the PDFF of the pancreas had a significant negative correlation with the SIR on FS-T1WI and a significant positive correlation with the T1 value, indicating that the T1 signal intensity of the pancreas was likely to decrease with increased pancreatic fat content. A normal pancreas has an intrinsically high T1 signal intensity due to the T1-shortening effect of acinar protein within the pancreatic parenchyma [<xref rid="B41-tomography-11-00016" ref-type="bibr">41</xref>]. Thus, our findings may be explained by the loss of acinar parenchyma associated with fatty infiltration in the pancreatic parenchyma in diabetes. Furthermore, the ADC values of the pancreas, the other suggested marker of fibrosis, showed a tendency to decrease with increased PDFF. This finding suggests that pancreatic fibrosis may be less likely to increase in cases of increased pancreatic fat content, as seen in patients with T2D in this study.</p><p>Regarding pancreatic exocrine function, we observed significant positive correlations between the mean secretion grade of pancreatic juice flow and the SIR on FS-T1WI associated with pancreatic fibrosis. Our findings suggest that pancreatic exocrine function may decrease with the progression of pancreatic fibrosis, which may be supported by previous studies demonstrating the increased pancreatic fibrosis and pancreatic exocrine dysfunction in both T1D and T2D [<xref rid="B42-tomography-11-00016" ref-type="bibr">42</xref>]. Although we observed no significant correlations between the mean secretion grade of pancreatic juice flow and PDFF of the pancreas, a significant degree of fatty infiltration in the pancreas can be associated with severe exocrine pancreatic insufficiency [<xref rid="B43-tomography-11-00016" ref-type="bibr">43</xref>]. Thus, further studies including diabetic patients with marked pancreatic fat deposition will be needed to evaluate the association between pancreatic fat content and pancreatic exocrine function in patients with diabetes.</p><p>In current clinical practice, laboratory tests are the cornerstone of the diagnosis and follow-up &#x0003c; of diabetes, and MRI has still had a limited impact on the management of diabetes. However, blood tests are subject to some important limitations and cannot fully reflect the pathophysiological features of diabetes [<xref rid="B44-tomography-11-00016" ref-type="bibr">44</xref>]. Recent studies have evaluated the longitudinal changes in pancreas volume and shape in patients with T1D using MRI [<xref rid="B45-tomography-11-00016" ref-type="bibr">45</xref>,<xref rid="B46-tomography-11-00016" ref-type="bibr">46</xref>]. Virostko et al. [<xref rid="B46-tomography-11-00016" ref-type="bibr">46</xref>] have shown that pancreatic volume measurements have the potential to predict the progression of T1D. Another study has demonstrated that the risk of onset of T2D increases with smaller pancreatic diameter and higher angle of pancreaticobiliary junction [<xref rid="B47-tomography-11-00016" ref-type="bibr">47</xref>]. These studies suggest the potential utility of MRI for monitoring the progression of diabetes and predicting its risk factors. In the present study, we demonstrated the MR imaging features of the pancreas reflecting the pancreatic endocrine and exocrine functions as well as pancreatic pathohistological changes in both patients with T1D and patients with T2D. Thus, multiparametric MRI may have the potential to improve our understanding of pancreatic changes in diabetes patients. Moreover, the application of multiparametric MRI to advanced image analysis techniques, such as radiomics, might have a potential role in improving diagnosis, monitoring disease progression, and assessing treatment response in these patients noninvasively. However, our study findings need to be validated by further clinical investigation using a large number of patients with diabetes. Additionally, it is necessary to assess the MR imaging findings over a long period and evaluate the correlation between MR imaging features, clinical findings, and treatments for future clinical applications.</p><p>Several limitations associated with the present study warrant mention. First, the number of patients with T1D was small due to the limited number of patients at our institution and our criteria for excluding genetic types of diabetes, which may have caused selection bias and may impact the generalizability and robustness of the imaging findings in patients with T1D. Moreover, the small sample size of patients with T1D and unbalanced sample size between groups may lead to reduced power, lower reproducibility, and lower accuracy in this study. The small effect size in some analyses may have been impacted by these factors. Second, the age of patients with T1D was significantly lower than that of T2D and control patients, and previous studies have shown that aging can affect the pancreas size, pancreatic fat content, pancreatic fibrosis, and pancreatic exocrine function [<xref rid="B37-tomography-11-00016" ref-type="bibr">37</xref>,<xref rid="B48-tomography-11-00016" ref-type="bibr">48</xref>,<xref rid="B49-tomography-11-00016" ref-type="bibr">49</xref>]. Thus, further studies with a larger population with T1D and the T2D and control patients adjusted for age and sample size will be required to validate our results by recruiting further diabetes patients and volunteer subjects in our institution and conducting a multicenter study. Third, we did not measure fecal elastase-1 (FE-1) in spot stool, which is the gold standard test for the assessment of pancreatic exocrine function. The evaluation of pancreatic exocrine function using cine-dynamic MRCP with a spatially selective IR pulse is an indirect method. Furthermore, the BT-PABA test, used as a reference standard for comparison with cine-dynamic MRCP, has inferior diagnostic ability for pancreatic exocrine function compared to the FE-1 test [<xref rid="B50-tomography-11-00016" ref-type="bibr">50</xref>]. Therefore, further validation using the FE-1 test as the reference standard is needed to establish cine-dynamic MRCP with a spatially selective IR pulse as a useful method for assessing the pancreatic exocrine function. Additionally, we measured the PDFF, T1, and ADC values using only a single slice for each part of the pancreas by ROI. This ROI-based measurement may induce measurement bias in a mosaic tissue such as the pancreas. For this reason, it is necessary to evaluate these images independently by multiple reviewers and measure these values using multiple slices in the future study. Finally, the imaging findings of the pancreas in patients with T2D may vary depending on the stage and duration of diabetes or treatment. Therefore, further clinical studies are needed to consider the clinical background of patients with T2D.</p></sec><sec sec-type="conclusions" id="sec5-tomography-11-00016"><title>5. Conclusions</title><p>Patients with T1D had a reduced pancreas size, increased pancreatic T1 and ADC values suggestive of increased pancreatic fibrosis and decreased pancreatic cellular density, and decreased pancreatic exocrine function estimated by cine-dynamic MRCP with a spatially selective IR pulse, whereas patients with T2D had an increased pancreatic fat content. Multiparametric MRI of the pancreas provided characteristic imaging findings in patients with T1D and patients with T2D and was considered clinically helpful in understanding the pathophysiology of these diseases.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, K.I.; methodology, K.I. and M.H.; software, M.T.; validation, K.I.; formal analysis, M.T.; investigation, M.H. and K.T. (Katsuya Tanabe); resources, K.T. (Katsuya Tanabe), S.O., K.T. (Koumei Takeda), and Y.N.; data curation, M.H. and K.T. (Katsuya Tanabe); writing&#x02014;original draft preparation, M.H. and K.T. (Katsuya Tanabe); writing&#x02014;review and editing, K.I.; visualization, M.H.; supervision, K.I.; project administration, K.I. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Yamaguchi University Hospital (protocol code: H2019-181-3; date of approval: 1 May 2020).</p></notes><notes><title>Informed Consent Statement</title><p>Informed consent was obtained from all subjects involved in the study.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The raw data supporting the conclusions of this article will be made available by the authors upon request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><p>T1D, type 1 diabetes; T2D, type 2 diabetes; IR, inversion-recovery; MRCP, magnetic resonance cholangiopancreatography; AP, anteroposterior; SIR, signal intensity ratio; FS-T1WI, fat-suppressed T1-weighted image; ADC, apparent diffusion coefficient; PDFF, proton density fat fraction; BMI, body mass index; HbA1c, hemoglobin A1c; FPG, fasting plasma glucose; CPR, C-peptide immunoreactivity; CPI, C-peptide index; TG, triglyceride; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; AST, aspartate aminotransferase; ALT, aspartate transaminase; Cr, creatinine.</p></glossary><ref-list><title>References</title><ref id="B1-tomography-11-00016"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<collab>American Diabetes Association</collab>
</person-group><article-title>Diagnosis and classification of diabetes mellitus</article-title><source>Diabetes Care</source><year>2013</year><volume>36</volume><issue>(Suppl. S1)</issue><fpage>S67</fpage><lpage>S74</lpage><pub-id pub-id-type="doi">10.2337/dc13-S067</pub-id><pub-id pub-id-type="pmid">23264425</pub-id>
</element-citation></ref><ref id="B2-tomography-11-00016"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tremblay</surname><given-names>J.</given-names></name>
<name><surname>Hamet</surname><given-names>P.</given-names></name>
</person-group><article-title>Environmental and genetic contributions to diabetes</article-title><source>Metab. Clin. Exp.</source><year>2019</year><volume>100s</volume><fpage>153952</fpage><pub-id pub-id-type="doi">10.1016/j.metabol.2019.153952</pub-id><pub-id pub-id-type="pmid">31610851</pub-id>
</element-citation></ref><ref id="B3-tomography-11-00016"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lindkvist</surname><given-names>B.</given-names></name>
</person-group><article-title>Diagnosis and treatment of pancreatic exocrine insufficiency</article-title><source>World J. Gastroenterol.</source><year>2013</year><volume>19</volume><fpage>7258</fpage><lpage>7266</lpage><pub-id pub-id-type="doi">10.3748/wjg.v19.i42.7258</pub-id><pub-id pub-id-type="pmid">24259956</pub-id>
</element-citation></ref><ref id="B4-tomography-11-00016"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zsori</surname><given-names>G.</given-names></name>
<name><surname>Illes</surname><given-names>D.</given-names></name>
<name><surname>Terzin</surname><given-names>V.</given-names></name>
<name><surname>Ivany</surname><given-names>E.</given-names></name>
<name><surname>Czako</surname><given-names>L.</given-names></name>
</person-group><article-title>Exocrine pancreatic insufficiency in type 1 and type 2 diabetes mellitus: Do we need to treat it? A systematic review</article-title><source>Pancreatology</source><year>2018</year><volume>18</volume><fpage>559</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1016/j.pan.2018.05.006</pub-id><pub-id pub-id-type="pmid">29779830</pub-id>
</element-citation></ref><ref id="B5-tomography-11-00016"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hricak</surname><given-names>H.</given-names></name>
<name><surname>Mayerhoefer</surname><given-names>M.E.</given-names></name>
<name><surname>Herrmann</surname><given-names>K.</given-names></name>
<name><surname>Lewis</surname><given-names>J.S.</given-names></name>
<name><surname>Pomper</surname><given-names>M.G.</given-names></name>
<name><surname>Hess</surname><given-names>C.P.</given-names></name>
<name><surname>Riklund</surname><given-names>K.</given-names></name>
<name><surname>Scott</surname><given-names>A.M.</given-names></name>
<name><surname>Weissleder</surname><given-names>R.</given-names></name>
</person-group><article-title>Advances and challenges in precision imaging</article-title><source>Lancet Oncol.</source><year>2025</year><volume>26</volume><fpage>e34</fpage><lpage>e45</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(24)00395-4</pub-id><pub-id pub-id-type="pmid">39756454</pub-id>
</element-citation></ref><ref id="B6-tomography-11-00016"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Basirinia</surname><given-names>G.</given-names></name>
<name><surname>Ali</surname><given-names>M.</given-names></name>
<name><surname>Comelli</surname><given-names>A.</given-names></name>
<name><surname>Sperandeo</surname><given-names>A.</given-names></name>
<name><surname>Piana</surname><given-names>S.</given-names></name>
<name><surname>Along</surname><given-names>P.</given-names></name>
<name><surname>Longo</surname><given-names>C.</given-names></name>
<name><surname>Raimondo</surname><given-names>D.D.</given-names></name>
<name><surname>Tuttolomondo</surname><given-names>A.</given-names></name>
<name><surname>Benfante</surname><given-names>V.</given-names></name>
</person-group><article-title>Theranostic Approaches for Gastric Cancer: An Overview of In Vitro and In Vivo Investigations</article-title><source>Cancers</source><year>2024</year><volume>16</volume><elocation-id>3323</elocation-id><pub-id pub-id-type="doi">10.3390/cancers16193323</pub-id><pub-id pub-id-type="pmid">39409942</pub-id>
</element-citation></ref><ref id="B7-tomography-11-00016"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qi</surname><given-names>Y.J.</given-names></name>
<name><surname>Su</surname><given-names>G.H.</given-names></name>
<name><surname>You</surname><given-names>C.</given-names></name>
<name><surname>Zhang</surname><given-names>X.</given-names></name>
<name><surname>Xiao</surname><given-names>Y.</given-names></name>
<name><surname>Jiang</surname><given-names>Y.Z.</given-names></name>
<name><surname>Shao</surname><given-names>Z.M.</given-names></name>
</person-group><article-title>Radiomics in breast cancer: Current advances and future directions</article-title><source>Cell Rep. Med.</source><year>2024</year><volume>5</volume><fpage>101719</fpage><pub-id pub-id-type="doi">10.1016/j.xcrm.2024.101719</pub-id><pub-id pub-id-type="pmid">39293402</pub-id>
</element-citation></ref><ref id="B8-tomography-11-00016"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cas&#x000e0;</surname><given-names>C.</given-names></name>
<name><surname>Piras</surname><given-names>A.</given-names></name>
<name><surname>D&#x02019;Aviero</surname><given-names>A.</given-names></name>
<name><surname>Preziosi</surname><given-names>F.</given-names></name>
<name><surname>Mariani</surname><given-names>S.</given-names></name>
<name><surname>Cusumano</surname><given-names>D.</given-names></name>
<name><surname>Romano</surname><given-names>A.</given-names></name>
<name><surname>Boskoski</surname><given-names>I.</given-names></name>
<name><surname>Lenkowicz</surname><given-names>J.</given-names></name>
<name><surname>Dinapoli</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>The impact of radiomics in diagnosis and staging of pancreatic cancer</article-title><source>Ther. Adv. Gastrointest. Endosc.</source><year>2022</year><volume>15</volume><fpage>26317745221081596</fpage><pub-id pub-id-type="doi">10.1177/26317745221081596</pub-id><pub-id pub-id-type="pmid">35342883</pub-id>
</element-citation></ref><ref id="B9-tomography-11-00016"><label>9.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Benfante</surname><given-names>V.</given-names></name>
<name><surname>Salvaggio</surname><given-names>G.</given-names></name>
<name><surname>Ali</surname><given-names>M.</given-names></name>
<name><surname>Cutaia</surname><given-names>G.</given-names></name>
<name><surname>Salvaggio</surname><given-names>L.</given-names></name>
<name><surname>Salerno</surname><given-names>S.</given-names></name>
<name><surname>Bus&#x000e8;</surname><given-names>G.</given-names></name>
<name><surname>Tulone</surname><given-names>G.</given-names></name>
<name><surname>Pavan</surname><given-names>N.</given-names></name>
<name><surname>Raimondo</surname><given-names>D.D.</given-names></name>
<etal/>
</person-group><article-title>Grading and Staging of Bladder Tumors Using Radiomics Analysis in Magnetic Resonance Imaging</article-title><source>Image Analysis and Processing&#x02014;ICIAP 2023 Workshops</source><person-group person-group-type="editor">
<name><surname>Foresti</surname><given-names>G.L.</given-names></name>
<name><surname>Fusiello</surname><given-names>A.</given-names></name>
<name><surname>Hancock</surname><given-names>E.</given-names></name>
</person-group><publisher-name>Springer Nature Switzerland</publisher-name><publisher-loc>Cham, Switzerland</publisher-loc><year>2024</year><fpage>93</fpage><lpage>103</lpage></element-citation></ref><ref id="B10-tomography-11-00016"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lu</surname><given-names>C.Q.</given-names></name>
<name><surname>Wang</surname><given-names>Y.C.</given-names></name>
<name><surname>Meng</surname><given-names>X.P.</given-names></name>
<name><surname>Zhao</surname><given-names>H.T.</given-names></name>
<name><surname>Zeng</surname><given-names>C.H.</given-names></name>
<name><surname>Xu</surname><given-names>W.</given-names></name>
<name><surname>Gao</surname><given-names>Y.T.</given-names></name>
<name><surname>Ju</surname><given-names>S.</given-names></name>
</person-group><article-title>Diabetes risk assessment with imaging: A radiomics study of abdominal CT</article-title><source>Eur. Radiol.</source><year>2019</year><volume>29</volume><fpage>2233</fpage><lpage>2242</lpage><pub-id pub-id-type="doi">10.1007/s00330-018-5865-5</pub-id><pub-id pub-id-type="pmid">30523453</pub-id>
</element-citation></ref><ref id="B11-tomography-11-00016"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jang</surname><given-names>S.</given-names></name>
<name><surname>Kim</surname><given-names>J.H.</given-names></name>
<name><surname>Choi</surname><given-names>S.Y.</given-names></name>
<name><surname>Park</surname><given-names>S.J.</given-names></name>
<name><surname>Han</surname><given-names>J.K.</given-names></name>
</person-group><article-title>Application of computerized 3D-CT texture analysis of pancreas for the assessment of patients with diabetes</article-title><source>PLoS ONE</source><year>2020</year><volume>15</volume><elocation-id>e0227492</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0227492</pub-id><pub-id pub-id-type="pmid">31929591</pub-id>
</element-citation></ref><ref id="B12-tomography-11-00016"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Virostko</surname><given-names>J.</given-names></name>
</person-group><article-title>Quantitative Magnetic Resonance Imaging of the Pancreas of Individuals With Diabetes</article-title><source>Front. Endocrinol.</source><year>2020</year><volume>11</volume><elocation-id>592349</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2020.592349</pub-id></element-citation></ref><ref id="B13-tomography-11-00016"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zeng</surname><given-names>N.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Cheng</surname><given-names>Y.</given-names></name>
<name><surname>Huang</surname><given-names>Z.</given-names></name>
<name><surname>Song</surname><given-names>B.</given-names></name>
</person-group><article-title>Imaging evaluation of the pancreas in diabetic patients</article-title><source>Abdom. Radiol.</source><year>2022</year><volume>47</volume><fpage>715</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1007/s00261-021-03340-0</pub-id><pub-id pub-id-type="pmid">34786594</pub-id>
</element-citation></ref><ref id="B14-tomography-11-00016"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garcia</surname><given-names>T.S.</given-names></name>
<name><surname>Rech</surname><given-names>T.H.</given-names></name>
<name><surname>Leit&#x000e3;o</surname><given-names>C.B.</given-names></name>
</person-group><article-title>Pancreatic size and fat content in diabetes: A systematic review and meta-analysis of imaging studies</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0180911</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0180911</pub-id><pub-id pub-id-type="pmid">28742102</pub-id>
</element-citation></ref><ref id="B15-tomography-11-00016"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Noda</surname><given-names>Y.</given-names></name>
<name><surname>Goshima</surname><given-names>S.</given-names></name>
<name><surname>Tsuji</surname><given-names>Y.</given-names></name>
<name><surname>Kajita</surname><given-names>K.</given-names></name>
<name><surname>Kawada</surname><given-names>H.</given-names></name>
<name><surname>Kawai</surname><given-names>N.</given-names></name>
<name><surname>Tanahashi</surname><given-names>Y.</given-names></name>
<name><surname>Matsuo</surname><given-names>M.</given-names></name>
</person-group><article-title>Correlation of quantitative pancreatic T1 value and HbA1c value in subjects with normal and impaired glucose tolerance</article-title><source>J. Magn. Reson. Imaging</source><year>2019</year><volume>49</volume><fpage>711</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1002/jmri.26242</pub-id><pub-id pub-id-type="pmid">30430688</pub-id>
</element-citation></ref><ref id="B16-tomography-11-00016"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<collab>The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus</collab>
<name><surname>Seino</surname><given-names>Y.</given-names></name>
<name><surname>Nanjo</surname><given-names>K.</given-names></name>
<name><surname>Tajima</surname><given-names>N.</given-names></name>
<name><surname>Kadowaki</surname><given-names>T.</given-names></name>
<name><surname>Kashiwagi</surname><given-names>A.</given-names></name>
<name><surname>Araki</surname><given-names>E.</given-names></name>
<name><surname>Ito</surname><given-names>C.</given-names></name>
<name><surname>Inagaki</surname><given-names>N.</given-names></name>
<name><surname>Iwamoto</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>Report of the committee on the classification and diagnostic criteria of diabetes mellitus</article-title><source>J. Diabetes Investig.</source><year>2010</year><volume>1</volume><fpage>212</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1007/s13340-010-0006-7</pub-id><pub-id pub-id-type="pmid">24843435</pub-id>
</element-citation></ref><ref id="B17-tomography-11-00016"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yamada</surname><given-names>Y.</given-names></name>
<name><surname>Fukuda</surname><given-names>K.</given-names></name>
<name><surname>Fujimoto</surname><given-names>S.</given-names></name>
<name><surname>Hosokawa</surname><given-names>M.</given-names></name>
<name><surname>Tsukiyama</surname><given-names>K.</given-names></name>
<name><surname>Nagashima</surname><given-names>K.</given-names></name>
<name><surname>Fukushima</surname><given-names>M.</given-names></name>
<name><surname>Suzuki</surname><given-names>H.</given-names></name>
<name><surname>Toyoda</surname><given-names>K.</given-names></name>
<name><surname>Sassa</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>SUIT, secretory units of islets in transplantation: An index for therapeutic management of islet transplanted patients and its application to type 2 diabetes</article-title><source>Diabetes Res. Clin. Pract.</source><year>2006</year><volume>74</volume><fpage>222</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2006.03.030</pub-id><pub-id pub-id-type="pmid">16707190</pub-id>
</element-citation></ref><ref id="B18-tomography-11-00016"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Watanabe</surname><given-names>H.</given-names></name>
<name><surname>Kanematsu</surname><given-names>M.</given-names></name>
<name><surname>Tanaka</surname><given-names>K.</given-names></name>
<name><surname>Osada</surname><given-names>S.</given-names></name>
<name><surname>Tomita</surname><given-names>H.</given-names></name>
<name><surname>Hara</surname><given-names>A.</given-names></name>
<name><surname>Goshima</surname><given-names>S.</given-names></name>
<name><surname>Kondo</surname><given-names>H.</given-names></name>
<name><surname>Kawada</surname><given-names>H.</given-names></name>
<name><surname>Noda</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>Fibrosis and postoperative fistula of the pancreas: Correlation with MR imaging findings--preliminary results</article-title><source>Radiology</source><year>2014</year><volume>270</volume><fpage>791</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1148/radiol.13131194</pub-id><pub-id pub-id-type="pmid">24475834</pub-id>
</element-citation></ref><ref id="B19-tomography-11-00016"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Noda</surname><given-names>Y.</given-names></name>
<name><surname>Goshima</surname><given-names>S.</given-names></name>
<name><surname>Tanaka</surname><given-names>K.</given-names></name>
<name><surname>Osada</surname><given-names>S.</given-names></name>
<name><surname>Tomita</surname><given-names>H.</given-names></name>
<name><surname>Hara</surname><given-names>A.</given-names></name>
<name><surname>Horikawa</surname><given-names>Y.</given-names></name>
<name><surname>Takeda</surname><given-names>J.</given-names></name>
<name><surname>Kajita</surname><given-names>K.</given-names></name>
<name><surname>Watanabe</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>Findings in pancreatic MRI associated with pancreatic fibrosis and HbA1c values</article-title><source>J. Magn. Reson. Imaging</source><year>2016</year><volume>43</volume><fpage>680</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1002/jmri.25019</pub-id><pub-id pub-id-type="pmid">26201823</pub-id>
</element-citation></ref><ref id="B20-tomography-11-00016"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sibley</surname><given-names>C.T.</given-names></name>
<name><surname>Noureldin</surname><given-names>R.A.</given-names></name>
<name><surname>Gai</surname><given-names>N.</given-names></name>
<name><surname>Nacif</surname><given-names>M.S.</given-names></name>
<name><surname>Liu</surname><given-names>S.</given-names></name>
<name><surname>Turkbey</surname><given-names>E.B.</given-names></name>
<name><surname>Mudd</surname><given-names>J.O.</given-names></name>
<name><surname>van der Geest</surname><given-names>R.J.</given-names></name>
<name><surname>Lima</surname><given-names>A.</given-names></name>
<name><surname>Halushka</surname><given-names>M.K.</given-names></name>
<etal/>
</person-group><article-title>T1 Mapping in cardiomyopathy at cardiac MR: Comparison with endomyocardial biopsy</article-title><source>Radiology</source><year>2012</year><volume>265</volume><fpage>724</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1148/radiol.12112721</pub-id><pub-id pub-id-type="pmid">23091172</pub-id>
</element-citation></ref><ref id="B21-tomography-11-00016"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yasokawa</surname><given-names>K.</given-names></name>
<name><surname>Ito</surname><given-names>K.</given-names></name>
<name><surname>Tamada</surname><given-names>T.</given-names></name>
<name><surname>Yamamoto</surname><given-names>A.</given-names></name>
<name><surname>Hayashida</surname><given-names>M.</given-names></name>
<name><surname>Tanimoto</surname><given-names>D.</given-names></name>
<name><surname>Higaki</surname><given-names>A.</given-names></name>
<name><surname>Noda</surname><given-names>Y.</given-names></name>
<name><surname>Kido</surname><given-names>A.</given-names></name>
</person-group><article-title>Noninvasive investigation of exocrine pancreatic function: Feasibility of cine dynamic MRCP with a spatially selective inversion-recovery pulse</article-title><source>J. Magn. Reson. Imaging</source><year>2015</year><volume>42</volume><fpage>1266</fpage><lpage>1271</lpage><pub-id pub-id-type="doi">10.1002/jmri.24906</pub-id><pub-id pub-id-type="pmid">25847877</pub-id>
</element-citation></ref><ref id="B22-tomography-11-00016"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ito</surname><given-names>K.</given-names></name>
<name><surname>Torigoe</surname><given-names>T.</given-names></name>
<name><surname>Tamada</surname><given-names>T.</given-names></name>
<name><surname>Yoshida</surname><given-names>K.</given-names></name>
<name><surname>Murakami</surname><given-names>K.</given-names></name>
<name><surname>Yoshimura</surname><given-names>M.</given-names></name>
</person-group><article-title>The secretory flow of pancreatic juice in the main pancreatic duct: Visualization by means of MRCP with spatially selective inversion-recovery pulse</article-title><source>Radiology</source><year>2011</year><volume>261</volume><fpage>582</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1148/radiol.11110162</pub-id><pub-id pub-id-type="pmid">21828187</pub-id>
</element-citation></ref><ref id="B23-tomography-11-00016"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Heuck</surname><given-names>A.</given-names></name>
<name><surname>Maubach</surname><given-names>P.A.</given-names></name>
<name><surname>Reiser</surname><given-names>M.</given-names></name>
<name><surname>Feuerbach</surname><given-names>S.</given-names></name>
<name><surname>Allgayer</surname><given-names>B.</given-names></name>
<name><surname>Lukas</surname><given-names>P.</given-names></name>
<name><surname>Kahn</surname><given-names>T.</given-names></name>
</person-group><article-title>Age-related morphology of the normal pancreas on computed tomography</article-title><source>Gastrointest. Radiol.</source><year>1987</year><volume>12</volume><fpage>18</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1007/BF01885094</pub-id><pub-id pub-id-type="pmid">3792751</pub-id>
</element-citation></ref><ref id="B24-tomography-11-00016"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Niederau</surname><given-names>C.</given-names></name>
<name><surname>Sonnenberg</surname><given-names>A.</given-names></name>
<name><surname>M&#x000fc;ller</surname><given-names>J.E.</given-names></name>
<name><surname>Erckenbrecht</surname><given-names>J.F.</given-names></name>
<name><surname>Scholten</surname><given-names>T.</given-names></name>
<name><surname>Fritsch</surname><given-names>W.P.</given-names></name>
</person-group><article-title>Sonographic measurements of the normal liver, spleen, pancreas, and portal vein</article-title><source>Radiology</source><year>1983</year><volume>149</volume><fpage>537</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1148/radiology.149.2.6622701</pub-id><pub-id pub-id-type="pmid">6622701</pub-id>
</element-citation></ref><ref id="B25-tomography-11-00016"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Williams</surname><given-names>J.A.</given-names></name>
<name><surname>Goldfine</surname><given-names>I.D.</given-names></name>
</person-group><article-title>The insulin-pancreatic acinar axis</article-title><source>Diabetes</source><year>1985</year><volume>34</volume><fpage>980</fpage><lpage>986</lpage><pub-id pub-id-type="doi">10.2337/diab.34.10.980</pub-id><pub-id pub-id-type="pmid">2412919</pub-id>
</element-citation></ref><ref id="B26-tomography-11-00016"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nakanishi</surname><given-names>K.</given-names></name>
<name><surname>Kobayashi</surname><given-names>T.</given-names></name>
<name><surname>Miyashita</surname><given-names>H.</given-names></name>
<name><surname>Okubo</surname><given-names>M.</given-names></name>
<name><surname>Sugimoto</surname><given-names>T.</given-names></name>
<name><surname>Murase</surname><given-names>T.</given-names></name>
<name><surname>Kosaka</surname><given-names>K.</given-names></name>
<name><surname>Hara</surname><given-names>M.</given-names></name>
</person-group><article-title>Relationships among residual beta cells, exocrine pancreas, and islet cell antibodies in insulin-dependent diabetes mellitus</article-title><source>Metab. Clin. Exp.</source><year>1993</year><volume>42</volume><fpage>196</fpage><lpage>203</lpage><pub-id pub-id-type="doi">10.1016/0026-0495(93)90035-M</pub-id><pub-id pub-id-type="pmid">7682643</pub-id>
</element-citation></ref><ref id="B27-tomography-11-00016"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tirkes</surname><given-names>T.</given-names></name>
<name><surname>Lin</surname><given-names>C.</given-names></name>
<name><surname>Fogel</surname><given-names>E.L.</given-names></name>
<name><surname>Sherman</surname><given-names>S.S.</given-names></name>
<name><surname>Wang</surname><given-names>Q.</given-names></name>
<name><surname>Sandrasegaran</surname><given-names>K.</given-names></name>
</person-group><article-title>T1 mapping for diagnosis of mild chronic pancreatitis</article-title><source>J. Magn. Reson. Imaging</source><year>2017</year><volume>45</volume><fpage>1171</fpage><lpage>1176</lpage><pub-id pub-id-type="doi">10.1002/jmri.25428</pub-id><pub-id pub-id-type="pmid">27519287</pub-id>
</element-citation></ref><ref id="B28-tomography-11-00016"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>&#x0015e;ahan</surname><given-names>M.H.</given-names></name>
<name><surname>&#x000d6;zdemir</surname><given-names>A.</given-names></name>
<name><surname>Asal</surname><given-names>N.</given-names></name>
<name><surname>Karadeniz Bilgili</surname><given-names>Y.M.</given-names></name>
<name><surname>Do&#x0011f;an</surname><given-names>A.</given-names></name>
<name><surname>G&#x000fc;ng&#x000fc;ne&#x0015f;</surname><given-names>A.</given-names></name>
</person-group><article-title>Pancreas and kidney changes in type 2 diabetes patients: The role of diffusion-weighted imaging</article-title><source>Turk. J. Med. Sci.</source><year>2021</year><volume>51</volume><fpage>1289</fpage><lpage>1295</lpage><pub-id pub-id-type="doi">10.3906/sag-2011-176</pub-id><pub-id pub-id-type="pmid">33535733</pub-id>
</element-citation></ref><ref id="B29-tomography-11-00016"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Noda</surname><given-names>Y.</given-names></name>
<name><surname>Goshima</surname><given-names>S.</given-names></name>
<name><surname>Tsuji</surname><given-names>Y.</given-names></name>
<name><surname>Kajita</surname><given-names>K.</given-names></name>
<name><surname>Akamine</surname><given-names>Y.</given-names></name>
<name><surname>Kawai</surname><given-names>N.</given-names></name>
<name><surname>Kawada</surname><given-names>H.</given-names></name>
<name><surname>Tanahashi</surname><given-names>Y.</given-names></name>
<name><surname>Matsuo</surname><given-names>M.</given-names></name>
</person-group><article-title>Pancreatic extracellular volume fraction using T1 mapping in patients with impaired glucose intolerance</article-title><source>Abdom. Radiol.</source><year>2020</year><volume>45</volume><fpage>449</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1007/s00261-019-02384-7</pub-id></element-citation></ref><ref id="B30-tomography-11-00016"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sarma</surname><given-names>M.K.</given-names></name>
<name><surname>Saucedo</surname><given-names>A.</given-names></name>
<name><surname>Darwin</surname><given-names>C.H.</given-names></name>
<name><surname>Felker</surname><given-names>E.R.</given-names></name>
<name><surname>Umachandran</surname><given-names>K.</given-names></name>
<name><surname>Kohanghadosh</surname><given-names>D.</given-names></name>
<name><surname>Xu</surname><given-names>E.</given-names></name>
<name><surname>Raman</surname><given-names>S.</given-names></name>
<name><surname>Thomas</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Noninvasive assessment of abdominal adipose tissues and quantification of hepatic and pancreatic fat fractions in type 2 diabetes mellitus</article-title><source>Magn. Reson. Imaging</source><year>2020</year><volume>72</volume><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1016/j.mri.2020.07.001</pub-id><pub-id pub-id-type="pmid">32668273</pub-id>
</element-citation></ref><ref id="B31-tomography-11-00016"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nadarajah</surname><given-names>C.</given-names></name>
<name><surname>Fananapazir</surname><given-names>G.</given-names></name>
<name><surname>Cui</surname><given-names>E.</given-names></name>
<name><surname>Gichoya</surname><given-names>J.</given-names></name>
<name><surname>Thayalan</surname><given-names>N.</given-names></name>
<name><surname>Asare-Sawiri</surname><given-names>M.</given-names></name>
<name><surname>Menias</surname><given-names>C.O.</given-names></name>
<name><surname>Sandrasegaran</surname><given-names>K.</given-names></name>
</person-group><article-title>Association of pancreatic fat content with type II diabetes mellitus</article-title><source>Clin. Radiol.</source><year>2020</year><volume>75</volume><fpage>51</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.crad.2019.05.027</pub-id><pub-id pub-id-type="pmid">31711639</pub-id>
</element-citation></ref><ref id="B32-tomography-11-00016"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tirkes</surname><given-names>T.</given-names></name>
<name><surname>Jeon</surname><given-names>C.Y.</given-names></name>
<name><surname>Li</surname><given-names>L.</given-names></name>
<name><surname>Joon</surname><given-names>A.Y.</given-names></name>
<name><surname>Seltman</surname><given-names>T.A.</given-names></name>
<name><surname>Sankar</surname><given-names>M.</given-names></name>
<name><surname>Persohn</surname><given-names>S.A.</given-names></name>
<name><surname>Territo</surname><given-names>P.R.</given-names></name>
</person-group><article-title>Association of Pancreatic Steatosis With Chronic Pancreatitis, Obesity, and Type 2 Diabetes Mellitus</article-title><source>Pancreas</source><year>2019</year><volume>48</volume><fpage>420</fpage><lpage>426</lpage><pub-id pub-id-type="doi">10.1097/MPA.0000000000001252</pub-id><pub-id pub-id-type="pmid">30747825</pub-id>
</element-citation></ref><ref id="B33-tomography-11-00016"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dong</surname><given-names>Z.</given-names></name>
<name><surname>Luo</surname><given-names>Y.</given-names></name>
<name><surname>Cai</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Peng</surname><given-names>Z.</given-names></name>
<name><surname>Jiang</surname><given-names>M.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>C.</given-names></name>
<name><surname>Li</surname><given-names>Z.P.</given-names></name>
<name><surname>Feng</surname><given-names>S.T.</given-names></name>
</person-group><article-title>Noninvasive fat quantification of the liver and pancreas may provide potential biomarkers of impaired glucose tolerance and type 2 diabetes</article-title><source>Medicine</source><year>2016</year><volume>95</volume><fpage>e3858</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000003858</pub-id><pub-id pub-id-type="pmid">27281097</pub-id>
</element-citation></ref><ref id="B34-tomography-11-00016"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Skudder-Hill</surname><given-names>L.</given-names></name>
<name><surname>Coffey</surname><given-names>S.</given-names></name>
<name><surname>Sequeira-Bisson</surname><given-names>I.R.</given-names></name>
<name><surname>Ko</surname><given-names>J.</given-names></name>
<name><surname>Poppitt</surname><given-names>S.D.</given-names></name>
<name><surname>Petrov</surname><given-names>M.S.</given-names></name>
</person-group><article-title>Comprehensive analysis of dyslipidemia states associated with fat in the pancreas</article-title><source>Diabetes Metab. Syndr.</source><year>2023</year><volume>17</volume><fpage>102881</fpage><pub-id pub-id-type="doi">10.1016/j.dsx.2023.102881</pub-id><pub-id pub-id-type="pmid">37862954</pub-id>
</element-citation></ref><ref id="B35-tomography-11-00016"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>M.K.</given-names></name>
<name><surname>Chun</surname><given-names>H.J.</given-names></name>
<name><surname>Park</surname><given-names>J.H.</given-names></name>
<name><surname>Yeo</surname><given-names>D.M.</given-names></name>
<name><surname>Baek</surname><given-names>K.H.</given-names></name>
<name><surname>Song</surname><given-names>K.H.</given-names></name>
<name><surname>Chung</surname><given-names>D.J.</given-names></name>
<name><surname>Kwon</surname><given-names>H.S.</given-names></name>
</person-group><article-title>The association between ectopic fat in the pancreas and subclinical atherosclerosis in type 2 diabetes</article-title><source>Diabetes Res. Clin. Pract.</source><year>2014</year><volume>106</volume><fpage>590</fpage><lpage>596</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2014.09.005</pub-id><pub-id pub-id-type="pmid">25444353</pub-id>
</element-citation></ref><ref id="B36-tomography-11-00016"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Regnell</surname><given-names>S.E.</given-names></name>
<name><surname>Peterson</surname><given-names>P.</given-names></name>
<name><surname>Trinh</surname><given-names>L.</given-names></name>
<name><surname>Broberg</surname><given-names>P.</given-names></name>
<name><surname>Leander</surname><given-names>P.</given-names></name>
<name><surname>Lernmark</surname><given-names>&#x000c5;.</given-names></name>
<name><surname>M&#x000e5;nsson</surname><given-names>S.</given-names></name>
<name><surname>Elding Larsson</surname><given-names>H.</given-names></name>
</person-group><article-title>Pancreas volume and fat fraction in children with Type 1 diabetes</article-title><source>Diabet. Med. A J. Br. Diabet. Assoc.</source><year>2016</year><volume>33</volume><fpage>1374</fpage><lpage>1379</lpage><pub-id pub-id-type="doi">10.1111/dme.13115</pub-id></element-citation></ref><ref id="B37-tomography-11-00016"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saisho</surname><given-names>Y.</given-names></name>
<name><surname>Butler</surname><given-names>A.E.</given-names></name>
<name><surname>Meier</surname><given-names>J.J.</given-names></name>
<name><surname>Monchamp</surname><given-names>T.</given-names></name>
<name><surname>Allen-Auerbach</surname><given-names>M.</given-names></name>
<name><surname>Rizza</surname><given-names>R.A.</given-names></name>
<name><surname>Butler</surname><given-names>P.C.</given-names></name>
</person-group><article-title>Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes</article-title><source>Clin. Anat.</source><year>2007</year><volume>20</volume><fpage>933</fpage><lpage>942</lpage><pub-id pub-id-type="doi">10.1002/ca.20543</pub-id><pub-id pub-id-type="pmid">17879305</pub-id>
</element-citation></ref><ref id="B38-tomography-11-00016"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zechner</surname><given-names>D.</given-names></name>
<name><surname>Knapp</surname><given-names>N.</given-names></name>
<name><surname>Bobrowski</surname><given-names>A.</given-names></name>
<name><surname>Radecke</surname><given-names>T.</given-names></name>
<name><surname>Genz</surname><given-names>B.</given-names></name>
<name><surname>Vollmar</surname><given-names>B.</given-names></name>
</person-group><article-title>Diabetes increases pancreatic fibrosis during chronic inflammation</article-title><source>Exp. Biol. Med.</source><year>2014</year><volume>239</volume><fpage>670</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1177/1535370214527890</pub-id><pub-id pub-id-type="pmid">24719378</pub-id>
</element-citation></ref><ref id="B39-tomography-11-00016"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kawamoto</surname><given-names>S.</given-names></name>
<name><surname>Siegelman</surname><given-names>S.S.</given-names></name>
<name><surname>Bluemke</surname><given-names>D.A.</given-names></name>
<name><surname>Hruban</surname><given-names>R.H.</given-names></name>
<name><surname>Fishman</surname><given-names>E.K.</given-names></name>
</person-group><article-title>Focal fatty infiltration in the head of the pancreas: Evaluation with multidetector computed tomography with multiplanar reformation imaging</article-title><source>J. Comput. Assist. Tomogr.</source><year>2009</year><volume>33</volume><fpage>90</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1097/RCT.0b013e31815cff0d</pub-id><pub-id pub-id-type="pmid">19188793</pub-id>
</element-citation></ref><ref id="B40-tomography-11-00016"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Matsumoto</surname><given-names>S.</given-names></name>
<name><surname>Mori</surname><given-names>H.</given-names></name>
<name><surname>Miyake</surname><given-names>H.</given-names></name>
<name><surname>Takaki</surname><given-names>H.</given-names></name>
<name><surname>Maeda</surname><given-names>T.</given-names></name>
<name><surname>Yamada</surname><given-names>Y.</given-names></name>
<name><surname>Oga</surname><given-names>M.</given-names></name>
</person-group><article-title>Uneven fatty replacement of the pancreas: Evaluation with CT</article-title><source>Radiology</source><year>1995</year><volume>194</volume><fpage>453</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1148/radiology.194.2.7824726</pub-id><pub-id pub-id-type="pmid">7824726</pub-id>
</element-citation></ref><ref id="B41-tomography-11-00016"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Semelka</surname><given-names>R.C.</given-names></name>
<name><surname>Ascher</surname><given-names>S.M.</given-names></name>
</person-group><article-title>MR imaging of the pancreas</article-title><source>Radiology</source><year>1993</year><volume>188</volume><fpage>593</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1148/radiology.188.3.8351317</pub-id><pub-id pub-id-type="pmid">8351317</pub-id>
</element-citation></ref><ref id="B42-tomography-11-00016"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mohapatra</surname><given-names>S.</given-names></name>
<name><surname>Majumder</surname><given-names>S.</given-names></name>
<name><surname>Smyrk</surname><given-names>T.C.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<name><surname>Matveyenko</surname><given-names>A.</given-names></name>
<name><surname>Kudva</surname><given-names>Y.C.</given-names></name>
<name><surname>Chari</surname><given-names>S.T.</given-names></name>
</person-group><article-title>Diabetes Mellitus Is Associated With an Exocrine Pancreatopathy: Conclusions From a Review of Literature</article-title><source>Pancreas</source><year>2016</year><volume>45</volume><fpage>1104</fpage><lpage>1110</lpage><pub-id pub-id-type="doi">10.1097/MPA.0000000000000609</pub-id><pub-id pub-id-type="pmid">26918874</pub-id>
</element-citation></ref><ref id="B43-tomography-11-00016"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Patel</surname><given-names>S.</given-names></name>
<name><surname>Bellon</surname><given-names>E.M.</given-names></name>
<name><surname>Haaga</surname><given-names>J.</given-names></name>
<name><surname>Park</surname><given-names>C.H.</given-names></name>
</person-group><article-title>Fat replacement of the exocrine pancreas</article-title><source>AJR Am. J. Roentgenol.</source><year>1980</year><volume>135</volume><fpage>843</fpage><lpage>845</lpage><pub-id pub-id-type="doi">10.2214/ajr.135.4.843</pub-id><pub-id pub-id-type="pmid">6778124</pub-id>
</element-citation></ref><ref id="B44-tomography-11-00016"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bonora</surname><given-names>E.</given-names></name>
<name><surname>Tuomilehto</surname><given-names>J.</given-names></name>
</person-group><article-title>The pros and cons of diagnosing diabetes with A1C</article-title><source>Diabetes Care</source><year>2011</year><volume>34</volume><issue>(Suppl. S2)</issue><fpage>S184</fpage><lpage>S190</lpage><pub-id pub-id-type="doi">10.2337/dc11-s216</pub-id><pub-id pub-id-type="pmid">21525453</pub-id>
</element-citation></ref><ref id="B45-tomography-11-00016"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wright</surname><given-names>J.J.</given-names></name>
<name><surname>Dulaney</surname><given-names>A.</given-names></name>
<name><surname>Williams</surname><given-names>J.M.</given-names></name>
<name><surname>Hilmes</surname><given-names>M.A.</given-names></name>
<name><surname>Du</surname><given-names>L.</given-names></name>
<name><surname>Kang</surname><given-names>H.</given-names></name>
<name><surname>Powers</surname><given-names>A.C.</given-names></name>
<name><surname>Moore</surname><given-names>D.J.</given-names></name>
<name><surname>Virostko</surname><given-names>J.</given-names></name>
</person-group><article-title>Longitudinal MRI Shows Progressive Decline in Pancreas Size and Altered Pancreas Shape in Type 1 Diabetes</article-title><source>J. Clin. Endocrinol. Metab.</source><year>2023</year><volume>108</volume><fpage>2699</fpage><lpage>2707</lpage><pub-id pub-id-type="doi">10.1210/clinem/dgad150</pub-id><pub-id pub-id-type="pmid">36938587</pub-id>
</element-citation></ref><ref id="B46-tomography-11-00016"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Virostko</surname><given-names>J.</given-names></name>
<name><surname>Wright</surname><given-names>J.J.</given-names></name>
<name><surname>Williams</surname><given-names>J.M.</given-names></name>
<name><surname>Hilmes</surname><given-names>M.A.</given-names></name>
<name><surname>Triolo</surname><given-names>T.M.</given-names></name>
<name><surname>Broncucia</surname><given-names>H.</given-names></name>
<name><surname>Du</surname><given-names>L.</given-names></name>
<name><surname>Kang</surname><given-names>H.</given-names></name>
<name><surname>Nallaparaju</surname><given-names>S.</given-names></name>
<name><surname>Valencia</surname><given-names>L.G.</given-names></name>
<etal/>
</person-group><article-title>Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 Diabetes</article-title><source>Diabetes Care</source><year>2024</year><volume>47</volume><fpage>393</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.2337/dc23-1681</pub-id><pub-id pub-id-type="pmid">38151474</pub-id>
</element-citation></ref><ref id="B47-tomography-11-00016"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yan</surname><given-names>Y.</given-names></name>
<name><surname>Wu</surname><given-names>T.</given-names></name>
<name><surname>Huang</surname><given-names>Z.</given-names></name>
<name><surname>Song</surname><given-names>X.</given-names></name>
<name><surname>Huang</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>N.</given-names></name>
</person-group><article-title>Risk Prediction of Type 2 Diabetes Mellitus by MRI-based Pancreatic Morphology and Clinical Characteristics: A Cross-sectional Study</article-title><source>Curr. Med. Imaging</source><year>2024</year><volume>20</volume><fpage>e15734056304038</fpage><pub-id pub-id-type="doi">10.2174/0115734056304038240515101952</pub-id><pub-id pub-id-type="pmid">38874042</pub-id>
</element-citation></ref><ref id="B48-tomography-11-00016"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Detlefsen</surname><given-names>S.</given-names></name>
<name><surname>Sipos</surname><given-names>B.</given-names></name>
<name><surname>Feyerabend</surname><given-names>B.</given-names></name>
<name><surname>Kl&#x000f6;ppel</surname><given-names>G.</given-names></name>
</person-group><article-title>Pancreatic fibrosis associated with age and ductal papillary hyperplasia</article-title><source>Virchows Arch.</source><year>2005</year><volume>447</volume><fpage>800</fpage><lpage>805</lpage><pub-id pub-id-type="doi">10.1007/s00428-005-0032-1</pub-id><pub-id pub-id-type="pmid">16021508</pub-id>
</element-citation></ref><ref id="B49-tomography-11-00016"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Laugier</surname><given-names>R.</given-names></name>
<name><surname>Bernard</surname><given-names>J.P.</given-names></name>
<name><surname>Berthezene</surname><given-names>P.</given-names></name>
<name><surname>Dupuy</surname><given-names>P.</given-names></name>
</person-group><article-title>Changes in pancreatic exocrine secretion with age: Pancreatic exocrine secretion does decrease in the elderly</article-title><source>Digestion</source><year>1991</year><volume>50</volume><fpage>202</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1159/000200762</pub-id><pub-id pub-id-type="pmid">1812045</pub-id>
</element-citation></ref><ref id="B50-tomography-11-00016"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Takeda</surname><given-names>M.</given-names></name>
<name><surname>Shiratori</surname><given-names>K.</given-names></name>
<name><surname>Hayashi</surname><given-names>N.</given-names></name>
<name><surname>Odagiri</surname><given-names>E.</given-names></name>
<name><surname>Takasaki</surname><given-names>K.</given-names></name>
</person-group><article-title>Fecal elastase-1 test: Clinical evaluation of a new noninvasive pancreatic function test</article-title><source>Rinsho Byori</source><year>2002</year><volume>50</volume><fpage>893</fpage><lpage>898</lpage><pub-id pub-id-type="pmid">12386968</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="tomography-11-00016-f001"><label>Figure 1</label><caption><p>(<bold>a</bold>) MRCP image without a spatially selective IR pulse obtained as a reference image. (<bold>b</bold>) The static pancreatic juice within the area of the spatially selective IR pulse (the area of 20 mm width between the parallel white lines) showed a low signal intensity. (<bold>c</bold>) The pancreatic juice flow showed a high signal intensity (arrow) within the area of the IR pulse. The grade score of the pancreatic juice flow was classified as grade 3 (11&#x02013;15 mm).</p></caption><graphic xlink:href="tomography-11-00016-g001" position="float"/></fig><fig position="float" id="tomography-11-00016-f002"><label>Figure 2</label><caption><p>MR images from a 40-year-old woman with type 1 diabetes. On the fat-suppressed T1-weighted image (<bold>a</bold>), the average pancreas-to-muscle SIR was 1.08. On the ADC map (<bold>b</bold>), averaged ADC value of the pancreas was 1.86 &#x000d7; 10<sup>&#x02212;3</sup> mm<sup>2</sup>/s. On the T1 map (<bold>c</bold>), the averaged T1 value of the pancreas was 952 ms. On the PDFF map (<bold>d</bold>), the average PDFF of the pancreas was 2.2%.</p></caption><graphic xlink:href="tomography-11-00016-g002" position="float"/></fig><fig position="float" id="tomography-11-00016-f003"><label>Figure 3</label><caption><p>MR images from a 53-year-old woman with type 2 diabetes. On the fat-suppressed T1-weighted image (<bold>a</bold>), the average pancreas-to-muscle SIR was 1.45. On the ADC map (<bold>b</bold>), averaged ADC value of the pancreas was 1.03 &#x000d7; 10<sup>&#x02212;3</sup> mm<sup>2</sup>/s. On the T1 map (<bold>c</bold>), the average T1 value of the pancreas was 719 ms. On the PDFF map (<bold>d</bold>), the average PDFF of the pancreas was 8.6%.</p></caption><graphic xlink:href="tomography-11-00016-g003" position="float"/></fig><table-wrap position="float" id="tomography-11-00016-t001"><object-id pub-id-type="pii">tomography-11-00016-t001_Table 1</object-id><label>Table 1</label><caption><p>MRI sequence parameters.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IP/OP </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">FS-T1WI</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">ADC Map</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">T1 Map</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PDFF Map</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cine-Dynamic MRCP</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">TR (ms)</td><td align="center" valign="middle" rowspan="1" colspan="1">125</td><td align="center" valign="middle" rowspan="1" colspan="1">3.4</td><td align="center" valign="middle" rowspan="1" colspan="1">1663</td><td align="center" valign="middle" rowspan="1" colspan="1">5.3</td><td align="center" valign="middle" rowspan="1" colspan="1">7.8</td><td align="center" valign="middle" rowspan="1" colspan="1">5000</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TE (ms)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.52/1.50</td><td align="center" valign="middle" rowspan="1" colspan="1">1.5</td><td align="center" valign="middle" rowspan="1" colspan="1">51</td><td align="center" valign="middle" rowspan="1" colspan="1">1.8</td><td align="center" valign="middle" rowspan="1" colspan="1">1.2, 2.2, 3.2, 4.2, 5.2, 6.2</td><td align="center" valign="middle" rowspan="1" colspan="1">507</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">acquisition matrix</td><td align="center" valign="middle" rowspan="1" colspan="1">224 &#x000d7; 288</td><td align="center" valign="middle" rowspan="1" colspan="1">256 &#x000d7; 288</td><td align="center" valign="middle" rowspan="1" colspan="1">200 &#x000d7; 128</td><td align="center" valign="middle" rowspan="1" colspan="1">192 &#x000d7; 256</td><td align="center" valign="middle" rowspan="1" colspan="1">144 &#x000d7; 160</td><td align="center" valign="middle" rowspan="1" colspan="1">512 &#x000d7; 512</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FOV (mm)</td><td align="center" valign="middle" rowspan="1" colspan="1">300 &#x000d7; 360</td><td align="center" valign="middle" rowspan="1" colspan="1">320 &#x000d7; 380</td><td align="center" valign="middle" rowspan="1" colspan="1">280 &#x000d7; 380</td><td align="center" valign="middle" rowspan="1" colspan="1">320 &#x000d7; 360</td><td align="center" valign="middle" rowspan="1" colspan="1">300 &#x000d7; 360</td><td align="center" valign="middle" rowspan="1" colspan="1">350 &#x000d7; 350</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">flip &#x0003c; angle (&#x000b0;)</td><td align="center" valign="middle" rowspan="1" colspan="1">70</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">90</td><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">3</td><td align="center" valign="middle" rowspan="1" colspan="1">150</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">slice thickness (mm)</td><td align="center" valign="middle" rowspan="1" colspan="1">5.0</td><td align="center" valign="middle" rowspan="1" colspan="1">1.5</td><td align="center" valign="middle" rowspan="1" colspan="1">5.0</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">2.3</td><td align="center" valign="middle" rowspan="1" colspan="1">50</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">band width (Hz/pixel)</td><td align="center" valign="middle" rowspan="1" colspan="1">976.5</td><td align="center" valign="middle" rowspan="1" colspan="1">781</td><td align="center" valign="middle" rowspan="1" colspan="1">3125</td><td align="center" valign="middle" rowspan="1" colspan="1">488</td><td align="center" valign="middle" rowspan="1" colspan="1">1302</td><td align="center" valign="middle" rowspan="1" colspan="1">558</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">interslice gap (mm)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.4</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">0.8</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">parallel imaging factor</td><td align="center" valign="middle" rowspan="1" colspan="1">1.5</td><td align="center" valign="middle" rowspan="1" colspan="1">2.5</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">acquisition time (s)</td><td align="center" valign="middle" rowspan="1" colspan="1">40 (20 &#x000d7; 2)</td><td align="center" valign="middle" rowspan="1" colspan="1">20</td><td align="center" valign="middle" rowspan="1" colspan="1">85</td><td align="center" valign="middle" rowspan="1" colspan="1">34 (17 &#x000d7; 2 slice)</td><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">b-factor (s/mm<sup>2</sup>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0, 1000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr></tbody></table><table-wrap-foot><fn><p>TR, repetition time; TE, echo time; FOV, field of view; IP, in-phase; OP, opposed-phase; FS-T1WI, fat-suppressed T1-weighted image; ADC, apparent diffusion coefficient; PDFF, proton density fat fraction; MRCP, magnetic resonance cholangiopancreatography.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tomography-11-00016-t002"><object-id pub-id-type="pii">tomography-11-00016-t002_Table 2</object-id><label>Table 2</label><caption><p>Patient characteristics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin" rowspan="1">T1D</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin" rowspan="1">T2D</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin" rowspan="1">Controls</th><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic> Value</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Value</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Value</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Value</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age (y) * </td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">48 (43&#x02013;51) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">63 (54&#x02013;70)</td><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">68 (59&#x02013;70)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.005</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Gender: male (%) <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">2</td><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">29</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">48</td><td align="center" valign="middle" rowspan="1" colspan="1">0.540</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age at diabetes onset (y) <sup>&#x02021;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">32 (25.5&#x02013;48.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">47.5 (42&#x02013;54)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.072</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Duration of diabetes (y) <sup>&#x02021;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">14 (6.5&#x02013;21)</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">13.5 (8.3&#x02013;19.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>) <sup>&#x000a7;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">22.0 &#x000b1; 2.2</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">25.9 &#x000b1; 3.9 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">22.0 &#x000b1; 3.7</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HbA1c (%) *</td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">7.3 (6.65&#x02013;7.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">7.1 (6.6&#x02013;8)</td><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">5.6 (5.5&#x02013;5.9) <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FPG (mg/dL) <sup>||</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">146 &#x000b1; 43.8</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">135 &#x000b1; 30.8</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.413</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CPR (ng/mL) <sup>&#x02021;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0&#x02013;0.85)</td><td align="center" valign="middle" rowspan="1" colspan="1">53</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (1.52&#x02013;2.82)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CPI <sup>&#x02021;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">0 (0&#x02013;0.63)</td><td align="center" valign="middle" rowspan="1" colspan="1">53</td><td align="center" valign="middle" rowspan="1" colspan="1">1.54 (1.09&#x02013;2.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Glucagon (pg/mL) <sup>&#x02021;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">14.3 (10.7&#x02013;38.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">53</td><td align="center" valign="middle" rowspan="1" colspan="1">24.7 (19.1&#x02013;34.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.276</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">P-Amylase (IU/l) <sup>&#x02021;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">12.5 (11.6&#x02013;20.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">53</td><td align="center" valign="middle" rowspan="1" colspan="1">29 (22&#x02013;37.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.008</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Lipase (IU/l) <sup>&#x02021;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">18 (16&#x02013;23)</td><td align="center" valign="middle" rowspan="1" colspan="1">53</td><td align="center" valign="middle" rowspan="1" colspan="1">37 (28&#x02013;53)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">TG (mg/dL) <sup>&#x02021;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">70 (45&#x02013;75)</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">126 (99&#x02013;173)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HDL-C (mg/dL) <sup>&#x02021;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">81 (65&#x02013;88)</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">51 (45&#x02013;64)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LDL-C (mg/dL) <sup>||</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">114 &#x000b1; 19</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">103 &#x000b1; 26</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.329</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AST (IU/L) <sup>&#x02021;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">15 (13&#x02013;19)</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">22 (18&#x02013;28)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.014</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ALT (IU/L) <sup>&#x02021;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">15 (11&#x02013;17)</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">25 (17&#x02013;31)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.007</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cr (mg/dL) <sup>||</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">7</td><td align="center" valign="middle" rowspan="1" colspan="1">0.69 &#x000b1; 0.10</td><td align="center" valign="middle" rowspan="1" colspan="1">54</td><td align="center" valign="middle" rowspan="1" colspan="1">0.81 &#x000b1; 0.23</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.192</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Urine albumin (mg/g&#x000b7;Cr) <sup>&#x02021;</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.1 (4.9&#x02013;9.5)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.0 (8.9&#x02013;49.4)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>0.030</bold>
</td></tr></tbody></table><table-wrap-foot><fn><p>Data are mean &#x000b1; standard deviation or median with 25th and 75th percentiles in parentheses. T1D, type 1 diabetes; T2D, type 2 diabetes; BMI, body mass index; HbA1c, hemoglobin A1c; FPG, fasting plasma glucose; CPR, C-peptide immunoreactivity; CPI, C-peptide index; TG, triglyceride; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; AST, aspartate aminotransferase; ALT, aspartate transaminase; Cr, creatinine; * Kruskal&#x02013;Wallis test, &#x02020; Fisher&#x02019;s exact test, &#x02021; Mann&#x02013;Whitney <italic toggle="yes">U</italic> test, &#x000a7; One-way analysis of variance, || Two-sample <italic toggle="yes">t</italic>-test. <sup>a</sup> Value was significantly lower (<italic toggle="yes">p &#x0003c;</italic> 0.05) than that in T2D and controls. <sup>b</sup> Value was significantly higher (<italic toggle="yes">p &#x0003c;</italic> 0.05) than that in T1D and controls. <sup>c</sup> Value was significantly lower (<italic toggle="yes">p &#x0003c;</italic> 0.001) than that in T1D and T2D. The values in bold denote statistical significance.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tomography-11-00016-t003"><object-id pub-id-type="pii">tomography-11-00016-t003_Table 3</object-id><label>Table 3</label><caption><p>Comparison of MR measurements among the T1D, T2D, and control groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">T1D <break/>(n = 7)</th><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">T2D<break/>(n = 54) </th><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Controls<break/>(n = 21) </th><th colspan="4" align="center" valign="middle" style="border-top:solid thin" rowspan="1"><italic toggle="yes">p</italic> Value </th><th colspan="4" align="center" valign="middle" style="border-top:solid thin" rowspan="1">Effect Size<break/><italic toggle="yes">&#x003b7;<sup>2</sup>&#x02003;&#x02003;&#x02003; r</italic></th></tr><tr><th align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Region</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x02013;2</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x02013;3</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x02013;3</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x02013;2</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#x02013;3</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2&#x02013;3</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">AP diameter (mm) *</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Head</td><td align="center" valign="middle" rowspan="1" colspan="1">19.1 &#x000b1; 2.8</td><td align="center" valign="middle" rowspan="1" colspan="1">27.0 &#x000b1; 5.9</td><td align="center" valign="middle" rowspan="1" colspan="1">24.1 &#x000b1; 4.9</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.002</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.099</td><td align="center" valign="middle" rowspan="1" colspan="1">0.106</td><td align="center" valign="middle" rowspan="1" colspan="1">0.16</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Body</td><td align="center" valign="middle" rowspan="1" colspan="1">10.2 &#x000b1; 2.3</td><td align="center" valign="middle" rowspan="1" colspan="1">17.0 &#x000b1; 5.2</td><td align="center" valign="middle" rowspan="1" colspan="1">17.3 &#x000b1; 5.3</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.004</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.004</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.006</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.964</td><td align="center" valign="middle" rowspan="1" colspan="1">0.13</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Tail</td><td align="center" valign="middle" rowspan="1" colspan="1">12.8 &#x000b1; 4.7</td><td align="center" valign="middle" rowspan="1" colspan="1">20.0 &#x000b1; 5.5</td><td align="center" valign="middle" rowspan="1" colspan="1">18.6 &#x000b1; 4.4</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.003</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.002</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.029</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.566</td><td align="center" valign="middle" rowspan="1" colspan="1">0.14</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">FS-T1WI SIR <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Averaged</td><td align="center" valign="middle" rowspan="1" colspan="1">1.24 (1.18&#x02013;1.34)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.41 (1.32&#x02013;1.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.52 (1.47&#x02013;1.61)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.059</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.006</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.32</td><td align="center" valign="middle" rowspan="1" colspan="1">0.67</td><td align="center" valign="middle" rowspan="1" colspan="1">0.36</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Head</td><td align="center" valign="middle" rowspan="1" colspan="1">1.26 (1.04&#x02013;1.30)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.37 (1.28&#x02013;1.46)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.49 (1.46&#x02013;1.62)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.061</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.004</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.32</td><td align="center" valign="middle" rowspan="1" colspan="1">0.68</td><td align="center" valign="middle" rowspan="1" colspan="1">0.38</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Body</td><td align="center" valign="middle" rowspan="1" colspan="1">1.25 (1.20&#x02013;1.37)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.49 (1.42&#x02013;1.57)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.52 (1.47&#x02013;1.69)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.002</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.008</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.583</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.39</td><td align="center" valign="middle" rowspan="1" colspan="1">0.64</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Tail</td><td align="center" valign="middle" rowspan="1" colspan="1">1.23 (1.21&#x02013;1.37)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.37 (1.27&#x02013;1.49)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.50 (1.43&#x02013;1.67)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.003</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.533</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.011</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.015</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.17</td><td align="center" valign="middle" rowspan="1" colspan="1">0.54</td><td align="center" valign="middle" rowspan="1" colspan="1">0.33</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ADC value<break/>(&#x000d7;10<sup>&#x02212;3</sup> mm<sup>2</sup>/s) <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Averaged</td><td align="center" valign="middle" rowspan="1" colspan="1">1.40 (1.34&#x02013;1.55)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.15 (1.09&#x02013;1.23)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.24 (1.13&#x02013;1.31)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.015</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.352</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.50</td><td align="center" valign="middle" rowspan="1" colspan="1">0.59</td><td align="center" valign="middle" rowspan="1" colspan="1">0.19</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Head</td><td align="center" valign="middle" rowspan="1" colspan="1">1.48 (1.37&#x02013;1.66)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.09 (1.03&#x02013;1.22)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.18 (1.09&#x02013;1.30)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.058</td><td align="center" valign="middle" rowspan="1" colspan="1">0.103</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.47</td><td align="center" valign="middle" rowspan="1" colspan="1">0.53</td><td align="center" valign="middle" rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Body</td><td align="center" valign="middle" rowspan="1" colspan="1">1.40 (1.40&#x02013;1.58)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.17 (1.11&#x02013;1.28)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.23 (1.13&#x02013;1.36)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.013</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.678</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.49</td><td align="center" valign="middle" rowspan="1" colspan="1">0.54</td><td align="center" valign="middle" rowspan="1" colspan="1">0.14</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Tail</td><td align="center" valign="middle" rowspan="1" colspan="1">1.43 (1.26&#x02013;1.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.18 (1.09&#x02013;1.27)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.19 (1.13&#x02013;1.32)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.036</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.033</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.199</td><td align="center" valign="middle" rowspan="1" colspan="1">1.000</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.31</td><td align="center" valign="middle" rowspan="1" colspan="1">0.40</td><td align="center" valign="middle" rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">T1 value (ms) <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Averaged</td><td align="center" valign="middle" rowspan="1" colspan="1">902 (880&#x02013;936)</td><td align="center" valign="middle" rowspan="1" colspan="1">777 (731&#x02013;819)</td><td align="center" valign="middle" rowspan="1" colspan="1">793 (742&#x02013;838)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.002</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.010</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.000</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.43</td><td align="center" valign="middle" rowspan="1" colspan="1">0.65</td><td align="center" valign="middle" rowspan="1" colspan="1">0.08</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Head</td><td align="center" valign="middle" rowspan="1" colspan="1">940 (903&#x02013;977)</td><td align="center" valign="middle" rowspan="1" colspan="1">765 (730&#x02013;830)</td><td align="center" valign="middle" rowspan="1" colspan="1">783 (750&#x02013;842)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.008</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.000</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.47</td><td align="center" valign="middle" rowspan="1" colspan="1">0.64</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Body or tail</td><td align="center" valign="middle" rowspan="1" colspan="1">900 (830&#x02013;944)</td><td align="center" valign="middle" rowspan="1" colspan="1">781 (726&#x02013;812)</td><td align="center" valign="middle" rowspan="1" colspan="1">777 (742&#x02013;836)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.010</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.008</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.045</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.000</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.38</td><td align="center" valign="middle" rowspan="1" colspan="1">0.49</td><td align="center" valign="middle" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PDFF (%) <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Averaged</td><td align="center" valign="middle" rowspan="1" colspan="1">2.2 (2.0&#x02013;6.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">6.3 (4.0&#x02013;8.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.0 (2.5&#x02013;5.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.013</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.196</td><td align="center" valign="middle" rowspan="1" colspan="1">1.000</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.029</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.22</td><td align="center" valign="middle" rowspan="1" colspan="1">0.09</td><td align="center" valign="middle" rowspan="1" colspan="1">0.31</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Head</td><td align="center" valign="middle" rowspan="1" colspan="1">3.7 (2.6&#x02013;9.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">8.8 (4.7&#x02013;13.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.2 (3.1&#x02013;8.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.035</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.385</td><td align="center" valign="middle" rowspan="1" colspan="1">1.000</td><td align="center" valign="middle" rowspan="1" colspan="1">0.058</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.18</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">0.27</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Body</td><td align="center" valign="middle" rowspan="1" colspan="1">1.0 (0.9&#x02013;6.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.9 (3.4&#x02013;7.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.5 (2.5&#x02013;4.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.032</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.238</td><td align="center" valign="middle" rowspan="1" colspan="1">1.000</td><td align="center" valign="middle" rowspan="1" colspan="1">0.078</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.20</td><td align="center" valign="middle" rowspan="1" colspan="1">0.15</td><td align="center" valign="middle" rowspan="1" colspan="1">0.27</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Tail</td><td align="center" valign="middle" rowspan="1" colspan="1">3.1 (1.8&#x02013;5.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">4.8 (3.2&#x02013;8.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">3.2 (1.8&#x02013;4.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.019</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.463</td><td align="center" valign="middle" rowspan="1" colspan="1">1.000</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.024</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.18</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">0.31</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">cine-dynamic MRCP <sup>&#x02020;</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Frequency of pancreatic juice flow </td><td align="center" valign="middle" rowspan="1" colspan="1">3 (0&#x02013;9)</td><td align="center" valign="middle" rowspan="1" colspan="1">12 (5&#x02013;16.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">15 (12&#x02013;19)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.013</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.251</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.016</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.127</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.24</td><td align="center" valign="middle" rowspan="1" colspan="1">0.47</td><td align="center" valign="middle" rowspan="1" colspan="1">0.24</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mean secretion grade of pancreatic juice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.15 (0&#x02013;0.625)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.825 (0.25&#x02013;1.425)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.05 (0.65&#x02013;2.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>0.021</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.156</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>0.019</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.327</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.49</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.19</td></tr></tbody></table><table-wrap-foot><fn><p>Data are mean &#x000b1; standard deviation or median with 25th and 75th percentiles in parentheses. T1D, type 1 diabetes; T2D, type 2 diabetes; AP, anteroposterior; FS-T1WI, fat-suppressed T1-weighted image; SIR, signal intensity ratio; ADC, apparent diffusion coefficient; PDFF, proton density fat fraction; MRCP, magnetic resonance cholangiopancreatography. * One-way analysis of variance with Tukey&#x02019;s post hoc test, &#x02020; Kruskal&#x02013;Wallis test with Dunn&#x02019;s post hoc test. The values in bold denote statistical significance.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tomography-11-00016-t004"><object-id pub-id-type="pii">tomography-11-00016-t004_Table 4</object-id><label>Table 4</label><caption><p>Correlation between MR measurements in patients with diabetes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Variables</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">1</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">3</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">4</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">5</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">6</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">1. AP diameter </td><td align="left" valign="middle" rowspan="1" colspan="1">Head</td><td rowspan="3" align="center" valign="middle" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.019</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.120</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.175</td><td align="center" valign="middle" rowspan="1" colspan="1">0.330 **</td><td align="center" valign="middle" rowspan="1" colspan="1">0.027</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">Body</td><td align="center" valign="middle" rowspan="1" colspan="1">0.085</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.239</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.407 **</td><td align="center" valign="middle" rowspan="1" colspan="1">0.092</td><td align="center" valign="middle" rowspan="1" colspan="1">0.037</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">Tail</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.146</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.185</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.342 **</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.017</td><td align="center" valign="middle" rowspan="1" colspan="1">0.051</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">2. FS-T1WI SIR </td><td align="left" valign="middle" rowspan="1" colspan="1">Head</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.145</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.478 ***</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.360 **</td><td align="center" valign="middle" rowspan="1" colspan="1">0.293 *</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">Body</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.060</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.291 *</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.262 *</td><td align="center" valign="middle" rowspan="1" colspan="1">0.392 **</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">Tail</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.170</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.139</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.238</td><td align="center" valign="middle" rowspan="1" colspan="1">0.198</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">3. ADC value</td><td align="left" valign="middle" rowspan="1" colspan="1">Head</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.233</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.247</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.063</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">Body</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.168</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.274 *</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.102</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">Tail</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.088</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.263 *</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.028</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">4. T1 value</td><td align="left" valign="middle" rowspan="1" colspan="1">Head</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="2" align="center" valign="middle" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.276 *</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.123</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">Body/Tail</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.171</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.094</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">5. PDFF</td><td align="left" valign="middle" rowspan="1" colspan="1">Head</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.059</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">Body</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.065</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
</td><td align="left" valign="middle" rowspan="1" colspan="1">Tail</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.057</td></tr><tr><td colspan="2" align="right" valign="middle" style="border-bottom:solid thin" rowspan="1">6. Mean secretion grade</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><fn><p>N = 61. * <italic toggle="yes">p</italic> &#x0003c; 0.05. ** <italic toggle="yes">p</italic> &#x0003c; 0.01. *** <italic toggle="yes">p</italic> &#x0003c; 0.001. AP, anteroposterior; FS-T1WI, fat-suppressed T1-weighted image; SIR, signal intensity ratio; ADC, apparent diffusion coefficient; PDFF, proton density fat fraction.</p></fn></table-wrap-foot></table-wrap></floats-group></article>